Skip to main content
SpringerLink
Log in

Aids Malignancies

  • Chapter
Aids-Associated Viral Oncogenesis

Part of the book series: Cancer Treatment and Research ((CTAR,volume 133))

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 129.00
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Ruf, I. K., A. Moghaddam, F. Wang, and J. Sample. 1999. Mechanisms that regulate Epstein-Barr virus EBNA-1 gene transcription during restricted latency are conserved among lymphocryptoviruses of Old World primates. J Virol 73(3):1980–9.

    PubMed  CAS  Google Scholar 

  2. Epstein, M. A., B. G. Achong, and Y. M. Barr. 1964. Virus particles in cultured lymphoblasts from Burkitt's lymphoma. Lancet 15:702–3.

    Google Scholar 

  3. Baer, R., A. T. Bankier, M. D. Biggin, P. L. Deininger, P. J. Farrell, T. J. Gibson, G. Hatfull, G. S. Hudson, S. C. Satchwell, C. Seguin, et al. 1984. DNA sequence and expression of the B95–8 Epstein-Barr virus genome. Nature 310(5974):207–11.

    PubMed  CAS  Google Scholar 

  4. Macsween, K. F., and D. H. Crawford. 2003. Epstein-Barr virus-recent advances. Lancet Infect Dis 3(3):131–40.

    PubMed  Google Scholar 

  5. Ambinder, R. F. 2001. Epstein-Barr virus associated lymphoproliferations in the AIDS setting. Eur J Cancer 37(10):1209–16.

    PubMed  CAS  Google Scholar 

  6. McClain, K. L., C. T. Leach, H. B. Jenson, V. V. Joshi, B. H. Pollock, R. T. Parmley, F. J. DiCarlo, E. G. Chadwick, and S. B. Murphy. 1995. Association of Epstein-Barr virus with leiomyosarcomas in children with AIDS. N Engl J Med 332(1):12–8.

    PubMed  CAS  Google Scholar 

  7. Jenson, H. B., C. T. Leach, K. L. McClain, V. V. Joshi, B. H. Pollock, R. T. Parmley, E. G. Chadwick, and S. B. Murphy. 1997. Benign and malignant smooth muscle tumors containing Epstein-Barr virus in children with AIDS. Leuk Lymphoma 27(3–4):303–14.

    PubMed  CAS  Google Scholar 

  8. Jenson, H. B., E. A. Montalvo, K. L. McClain, Y. Ench, P. Heard, B. A. Christy, P. J. Dewalt-Hagan, and M. P. Moyer. 1999. Characterization of natural Epstein-Barr virus infection and replication in smooth muscle cells from a leiomyosarcoma. J Med Virol 57(1):36–46.

    PubMed  CAS  Google Scholar 

  9. Birx, D. L., R. R. Redfield, and G. Tosato. 1986. Defective regulation of Epstein-Barr virus infection in patients with acquired immunodeficiency syndrome (AIDS) or AIDS-related disorders. N Engl J Med 314(14):874–9.

    PubMed  CAS  Google Scholar 

  10. Knowles, D. M. 1996. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 10(5):1081–109.

    PubMed  CAS  Google Scholar 

  11. Olson, J. E., C. A. Janney, R. D. Rao, J. R. Cerhan, P. J. Kurtin, D. Schiff, R. S. Kaplan, and B. P. O'Neill. 2002. The continuing increase in the incidence of primary central nervous system non-Hodgkin lymphoma: a surveillance, epidemiology, and end results analysis. Cancer 95(7):1504–10.

    PubMed  Google Scholar 

  12. Corn, B. W., S. M. Marcus, A. Topham, W. Hauck, and W. J. Curran, Jr. 1997. Will primary central nervous system lymphoma be the most frequent brain tumor diagnosed in the year 2000? Cancer 79(12): 2409–13.

    Google Scholar 

  13. Levine, A. M. 1992. Acquired immunodeficiency syndrome-related lymphoma. Blood 80(1):8–20.

    PubMed  CAS  Google Scholar 

  14. MacMahon, E. M., J. D. Glass, S. D. Hayward, R. B. Mann, P. S. Becker, P. Charache, J. C. McArthur, and R. F. Ambinder. 1991. Epstein-Barr virus in AIDS-related primary central nervous system lymphoma. Lancet 338(8773):969–73.

    PubMed  CAS  Google Scholar 

  15. Subar, M., A. Neri, G. Inghirami, D. M. Knowles, and R. Dalla-Favera. 1988. Frequent c-myc oncogene activation and infrequent presence of Epstein-Barr virus genome in AIDS-associated lymphoma. Blood 72(2):667–71.

    PubMed  CAS  Google Scholar 

  16. Ballerini, P., G. Gaidano, J. Z. Gong, V. Tassi, G. Saglio, D. M. Knowles, and R. Dalla-Favera. 1993. Multiple genetic lesions in acquired immunodeficiency syndrome-related non-Hodgkin's lymphoma. Blood 81(1):166–76.

    PubMed  CAS  Google Scholar 

  17. Hamilton-Dutoit, S. J., G. Pallesen, J. Karkov, P. Skinhoj, M. B. Franzmann, and C. Pedersen. 1989. Identification of EBV-DNA in tumour cells of AIDS-related lymphomas by in-situ hybridisation. Lancet 1(8637):554–62.

    PubMed  CAS  Google Scholar 

  18. Arribas, J. R., D. B. Clifford, C. J. Fichtenbaum, R. L. Roberts, W. G. Powderly, and G. A. Storch. 1995. Detection of Epstein-Barr virus DNA in cerebrospinal fluid for diagnosis of AIDS-related central nervous system lymphoma. J Clin Microbiol 33(6):1580–3.

    PubMed  CAS  Google Scholar 

  19. Cingolani, A., A. De Luca, L. M. Larocca, A. Ammassari, M. Scerrati, A. Antinori, and L. Ortona. 1998. Minimally invasive diagnosis of acquired immunodeficiency syndrome-related primary central nervous system lymphoma. J Natl Cancer Inst 90(5):364–9.

    PubMed  CAS  Google Scholar 

  20. Cinque, P., L. Vago, H. Dahl, M. Brytting, M. R. Terreni, C. Fornara, S. Racca, A. Castagna, A. D. Monforte, B. Wahren, A. Lazzarin, and A. Linde. 1996. Polymerase chain reaction on cerebrospinal fluid for diagnosis of virus-associated opportunistic diseases of the central nervous system in HIV-infected patients. AIDS 10(9):951–8.

    PubMed  CAS  Google Scholar 

  21. Bossolasco, S., P. Cinque, M. Ponzoni, M. G. Vigano, A. Lazzarin, A. Linde, and K. I. Falk. 2002. Epstein-Barr virus DNA load in cerebrospinal fluid and plasma of patients with AIDS-related lymphoma. J Neurovirol 8(5):432–8.

    PubMed  CAS  Google Scholar 

  22. Brink, N. S., Y. Sharvell, M. R. Howard, J. D. Fox, M. J. Harrison, and R. F. Miller. Detection of Epstein-Barr virus and Kaposi's sarcoma-associated herpesvirus DNA in CSF from persons infected with HIV who had neurological disease. J Neurol Neurosurg Psychiatry 65(2):191–5.

    Google Scholar 

  23. Cingolani, A., R. Gastaldi, L. Fassone, F. Pierconti, M. L. Giancola, M. Martini, A. De Luca, A. Ammassari, C. Mazzone, E. Pescarmona, G. Gaidano, L. M. Larocca, and A. Antinori. 2000. Epstein-Barr virus infection is predictive of CNS involvement in systemic AIDS-related non-Hodgkin's lymphomas. J Clin Oncol 18(19):3325–30.

    PubMed  CAS  Google Scholar 

  24. al-Shahi, R., M. Bower, M. R. Nelson, and B. G. Gazzard. 2000. Cerebrospinal fluid Epstein-Barr virus detection preceding HIV-associated primary central nervous system lymphoma by 17 months. J Neurol 247(6):471–2.

    Google Scholar 

  25. Cote, T. R., A. Manns, C. R. Hardy, F. J. Yellin, and P. Hartge. 1996. Epidemiology of brain lymphoma among people with or without acquired immunodeficiency syndrome. AIDS/Cancer Study Group. J Natl Cancer Inst 88(10):675–9.****.

    Google Scholar 

  26. Wolf, T., H. R. Brodt, S. Fichtlscherer, K. Mantzsch, D. Hoelzer, E. B. Helm, P. S. Mitrou, and K. U. Chow. 2005. Changing incidence and prognostic factors of survival in AIDS-related non-Hodgkin's lymphoma in the era of highly active antiretroviral therapy (HAART). Leuk Lymphoma 46(2):207–15.

    PubMed  Google Scholar 

  27. Sacktor, N., R. H. Lyles, R. Skolasky, C. Kleeberger, O. A. Selnes, E. N. Miller, J. T. Becker, B. Cohen, and J. C. McArthur. 2001. HIV-associated neurologic disease incidence changes: multicenter AIDS Cohort Study, 1990–1998. Neurology 56(2):257–60.

    PubMed  CAS  Google Scholar 

  28. Conti, S., M. Masocco, P. Pezzotti, V. Toccaceli, M. Vichi, S. Boros, R. Urciuoli, C. Valdarchi, and G. Rezza. 2000. Differential impact of combined antiretroviral therapy on the survival of Italian patients with specific AIDS-defining illnesses. J Acquir Immune Defic Syndr 25(5):451–8.

    PubMed  CAS  Google Scholar 

  29. Loureiro, C., P. S. Gill, P. R. Meyer, R. Rhodes, M. U. Rarick, and A. M. Levine. 1988. Autopsy findings in AIDS-related lymphoma. Cancer 62(4):735–9.

    PubMed  CAS  Google Scholar 

  30. Fine, H. A., and R. J. Mayer. 1993. Primary central nervous system lymphoma. Ann Intern Med 119(11):1093–104.

    PubMed  CAS  Google Scholar 

  31. Rubenstein, J., and M. Berger. 2005. Management of primary central nervous system lymphoma and primary intraocular lymphoma. In: Volberding, P. A., J. M. Palefsky, editors. Viral and Immunological Malignancies. 1st ed. Hamilton: BC Decker; 2005, pp. 166–79.

    Google Scholar 

  32. Schultz, C., C. Scott, W. Sherman, B. Donahue, J. Fields, K. Murray, B. Fisher, R. Abrams, and J. Meis-Kindblom. 1996. Preirradiation chemotherapy with cyclophosphamide, doxorubicin, vincristine, and dexamethasone for primary CNS lymphomas: initial report of radiation therapy oncology group protocol 88–06. J Clin Oncol 14(2):556–64.

    PubMed  CAS  Google Scholar 

  33. O'Neill, B. P., J. R. O'Fallon, J. D. Earle, J. P. Colgan, L. D. Brown, and R. L. Krigel. 1995. Primary central nervous system non-Hodgkin's lymphoma: survival advantages with combined initial therapy? Int J Radiat Oncol Biol Phys 33(3):663–73.

    PubMed  Google Scholar 

  34. Abrey, L. E., L. M. DeAngelis, and J. Yahalom. 1998. Long-term survival in primary CNS lymphoma. J Clin Oncol 16(3):859–63.

    PubMed  CAS  Google Scholar 

  35. Donahue, B. R., J. W. Sullivan, and J. S. Cooper. 1995. Additional experience with empiric radiotherapy for presumed human immunodeficiency virus-associated primary central nervous system lymphoma. Cancer 76(2):328–32.

    PubMed  CAS  Google Scholar 

  36. Baumgartner, J. E., J. R. Rachlin, J. H. Beckstead, T. C. Meeker, R. M. Levy, W. M. Wara, and M. L. Rosenblum. 1990. Primary central nervous system lymphomas: natural history and response to radiation therapy in 55 patients with acquired immunodeficiency syndrome. J Neurosurg 73(2):206–11.

    PubMed  CAS  Google Scholar 

  37. Goldstein, J. D., D. W. Dickson, F. G. Moser, A. D. Hirschfeld, K. Freeman, J. F. Llena, B. Kaplan, and L. Davis. 1991. Primary central nervous system lymphoma in acquired immune deficiency syndrome. A clinical and pathologic study with results of treatment with radiation. Cancer 67(11):2756–65.

    PubMed  CAS  Google Scholar 

  38. Kasamon, Y. L., and R. F. Ambinder. 2005. AIDS-related primary central nervous system lymphoma. Hematol Oncol Clin North Am 19(4):665–87, vi–vii.

    Google Scholar 

  39. Ambinder, R. F., S. Lee, W. J. Curran, Jr., et al. 2003. Phase II intergroup trial of sequential chemotherapy and radiotherapy for AIDS-related primary central nervous system lymphoma. Cancer Ther 1:215–21.

    Google Scholar 

  40. Chamberlain, M. C., and P. A. Kormanik. 1999. AIDS-related central nervous system lymphomas. J Neurooncol 43(3):269–76.

    PubMed  CAS  Google Scholar 

  41. Jacomet, C., P. M. Girard, M. G. Lebrette, V. L. Farese, L. Monfort, and W. Rozenbaum. 1997. Intravenous methotrexate for primary central nervous system non-Hodgkin's lymphoma in AIDS. AIDS 11(14):1725–30.

    PubMed  CAS  Google Scholar 

  42. Raez, L., L. Cabral, J. P. Cai, H. Landy, G. Sfakianakis, G. E. Byrne, Jr., J. Hurley, E. Scerpella, D. Jayaweera, and W. J. Harrington, Jr. 1999. Treatment of AIDS-related primary central nervous system lymphoma with zidovudine, ganciclovir, and interleukin 2. AIDS Res Hum Retroviruses 15(8):713–9.

    PubMed  CAS  Google Scholar 

  43. McGowan, J. P., and S. Shah. 1998. Long-term remission of AIDS-related primary central nervous system lymphoma associated with highly active antiretroviral therapy. AIDS 12(8):952–4.

    PubMed  CAS  Google Scholar 

  44. Hoffmann, C., S. Tabrizian, E. Wolf, C. Eggers, A. Stoehr, A. Plettenberg, T. Buhk, H. J. Stellbrink, H. A. Horst, H. Jager, and T. Rosenkranz. 2001. Survival of AIDS patients with primary central nervous system lymphoma is dramatically improved by HAART-induced immune recovery. AIDS 15(16):2119–27.

    PubMed  CAS  Google Scholar 

  45. Skiest, D. J., and C. Crosby. 2003. Survival is prolonged by highly active antiretroviral therapy in AIDS patients with primary central nervous system lymphoma. AIDS 17(12):1787–93.

    PubMed  Google Scholar 

  46. Carbone, A., and A. Gloghini. 2005. AIDS-related lymphomas: from pathogenesis to pathology. Br J Haematol 130(5):662–70.

    PubMed  CAS  Google Scholar 

  47. Doll, D. C., and A. F. List. 1982. Burkitt's lymphoma in a homosexual. Lancet 1(8279):1026–7.

    PubMed  CAS  Google Scholar 

  48. Ziegler, J. L., W. L. Drew, R. C. Miner, L. Mintz, E. Rosenbaum, J. Gershow, E. T. Lennette, J. Greenspan, E. Shillitoe, J. Beckstead, C. Casavant, and K. Yamamoto. 1982. Outbreak of Burkitt's-like lymphoma in homosexual men. Lancet 2(8299):631–3.

    PubMed  CAS  Google Scholar 

  49. Gates, A. E., and L. D. Kaplan. 2003. Biology and management of AIDS-associated non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 17(3):821–41.

    PubMed  Google Scholar 

  50. Beral, V., T. Peterman, R. Berkelman, and H. Jaffe. 1991. AIDS-associated non-Hodgkin lymphoma. Lancet 337(8745):805–9.

    PubMed  CAS  Google Scholar 

  51. Knowles, D. M., and A. Chadburn. 2001. Lymphadenopathy and the lymphoid neoplasms associated with the acquired immune deficiency syndrome. In: Knowles, D. M., editor. Neoplastic Hematopathology. Philadelphia: Lippincott-Williams; 2001, pp. 987–1089.

    Google Scholar 

  52. Levine, A. M., L. Seneviratne, B. M. Espina, A. R. Wohl, A. Tulpule, B. N. Nathwani, and P. S. Gill. 2000. Evolving characteristics of AIDS-related lymphoma. Blood 96(13):4084–90.

    PubMed  CAS  Google Scholar 

  53. Besson, C., A. Goubar, J. Gabarre, W. Rozenbaum, G. Pialoux, F. P. Chatelet, C. Katlama, F. Charlotte, B. Dupont, N. Brousse, M. Huerre, J. Mikol, P. Camparo, K. Mokhtari, M. Tulliez, D. Salmon-Ceron, F. Boue, D. Costagliola, and M. Raphael. 2001. Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy. Blood 98(8):2339–44.

    PubMed  CAS  Google Scholar 

  54. Raphael, M., B. Borisch, and E. Jaffe. 2001. Lymphomas associated with infection by the human immunodeficiency virus (HIV). In: Jaffe, E. S., N. L. Harris, and H. Stein, editors. World Health Organization Classification of Tumours: Pathology and Genetics Tumours of Haematopoietic and Lymphoid Tissues. Washington, DC: IARC Press; 2001.

    Google Scholar 

  55. Parekh, S., H. Ratech, and J. A. Sparano. 2003. Human immunodeficiency virus-associated lymphoma. Clin Adv Hematol Oncol 1(5):295–301.

    PubMed  Google Scholar 

  56. Ferry, J. A. 2006. Burkitt's Lymphoma: clinicopathologic features and differential diagnosis. Oncologist 11(4):375–83.

    PubMed  Google Scholar 

  57. Gong, J. Z., T. T. Stenzel, E. R. Bennett, A. S. Lagoo, C. H. Dunphy, J. O. Moore, D. A. Rizzieri, J. H. Tepperberg, P. Papenhausen, and P. J. Buckley. 2003. Burkitt lymphoma arising in organ transplant recipients: a clinicopathologic study of five cases. Am J Surg Pathol 27(6):818–27.

    PubMed  Google Scholar 

  58. Xicoy, B., J. M. Ribera, J. Esteve, S. Brunet, M. A. Sanz, P. Fernandez-Abellan, and E. Feliu. 2003. Post-transplant Burkitt's leukemia or lymphoma. Study of five cases treated with specific intensive therapy (PETHEMA ALL-3/97 trial). Leuk Lymphoma 44(9):1541–3.

    PubMed  Google Scholar 

  59. Blum, K. A., G. Lozanski, and J. C. Byrd. 2004. Adult Burkitt leukemia and lymphoma. Blood 104(10):3009–20.

    PubMed  CAS  Google Scholar 

  60. Kasamon, Y. L., and L. J. Swinnen. 2004. Treatment advances in adult Burkitt lymphoma and leukemia. Curr Opin Oncol 16(5):429–35.

    PubMed  Google Scholar 

  61. Knowles, D. M. 2003. Etiology and pathogenesis of AIDS-related non-Hodgkin's lymphoma. Hematol Oncol Clin North Am 17(3):785–820.

    PubMed  Google Scholar 

  62. Burmeister, T., S. Schwartz, H. A. Horst, H. Rieder, N. Gokbuget, D. Hoelzer, and E. Thiel. 2005. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features. Leukemia 19(8):1391–8.

    PubMed  CAS  Google Scholar 

  63. Diebold, J. Burkitt lymphoma. In: Jaffe, E., N. Harris, H. Stein, et al., editors. Pathology and Genetics of Tumours of Haematopoietic and Lymphoid Tissues. Washington, DC: IARC Press; 2001, pp. 181–4.

    Google Scholar 

  64. Knowles, D. M., G. A. Chamulak, M. Subar, J. S. Burke, M. Dugan, J. Wernz, C. Slywotzky, G. Pelicci, R. Dalla-Favera, and B. Raphael. 1988. Lymphoid neoplasia associated with the acquired immunodeficiency syndrome (AIDS). The New York University Medical Center experience with 105 patients (1981–1986). Ann Intern Med 108(5):744–53.

    PubMed  CAS  Google Scholar 

  65. Lim, S. T., R. Karim, B. N. Nathwani, A. Tulpule, B. Espina, and A. M. Levine. 2005. AIDS-related Burkitt's lymphoma versus diffuse large-cell lymphoma in the pre-highly active antiretroviral therapy (HAART) and HAART eras: significant differences in survival with standard chemotherapy. J Clin Oncol 23(19):4430–8.

    PubMed  CAS  Google Scholar 

  66. Cortes, J., D. Thomas, A. Rios, C. Koller, S. O'Brien, S. Jeha, S. Faderl, and H. Kantarjian. 2002. Hyperfractionated cyclophosphamide, vincristine, doxorubicin, and dexamethasone and highly active antiretroviral therapy for patients with acquired immunodeficiency syndrome-related Burkitt lymphoma/leukemia. Cancer 94(5):1492–9.

    PubMed  CAS  Google Scholar 

  67. Wang, E. S., D. J. Straus, J. Teruya-Feldstein, J. Qin, C. Portlock, C. Moskowitz, A. Goy, E. Hedrick, A. D. Zelenetz, and A. Noy. 2003. Intensive chemotherapy with cyclophosphamide, doxorubicin, high-dose methotrexate/ifosfamide, etoposide, and high-dose cytarabine (CODOX-M/IVAC) for human immunodeficiency virus-associated Burkitt lymphoma. Cancer 98(6):1196–205.

    PubMed  CAS  Google Scholar 

  68. Hamilton-Dutoit, S. J., M. Raphael, J. Audouin, J. Diebold, I. Lisse, C. Pedersen, E. Oksenhendler, L. Marelle, and G. Pallesen. 1993. In situ demonstration of Epstein-Barr virus small RNAs (EBER 1) in acquired immunodeficiency syndrome-related lymphomas: correlation with tumor morphology and primary site. Blood 82(2):619–24.

    PubMed  CAS  Google Scholar 

  69. Teruya-Feldstein, J., E. Chiao, D. A. Filippa, O. Lin, R. Comenzo, M. Coleman, C. Portlock, and A. Noy. 2004. CD20-negative large-cell lymphoma with plasmablastic features: a clinically heterogenous spectrum in both HIV-positive and -negative patients. Ann Oncol 15(11):1673–9.

    PubMed  CAS  Google Scholar 

  70. Liebowitz, D., and E. Kieff. 1989. Epstein-Barr virus latent membrane protein: induction of B-cell activation antigens and membrane patch formation does not require vimentin. J Virol 63(9):4051–4.

    PubMed  CAS  Google Scholar 

  71. Gaidano, G., and R. Dalla-Favera. Molecular pathogenesis of AIDS-related lymphomas. Adv Cancer Res 67:113–53.

    Google Scholar 

  72. Cote, T. R., R. J. Biggar, P. S. Rosenberg, S. S. Devesa, C. Percy, F. J. Yellin, G. Lemp, C. Hardy, J. J. Geodert, and W. A. Blattner. 1997. Non-Hodgkin's lymphoma among people with AIDS: incidence, presentation and public health burden. AIDS/Cancer Study Group. Int J Cancer 73(5):645–50.

    Google Scholar 

  73. Appleby, P., V. Beral, R. Newton, and G. Reeves. 2000. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92:1823–30.

    Google Scholar 

  74. Kirk, O., C. Pedersen, A. Cozzi-Lepri, F. Antunes, V. Miller, J. M. Gatell, C. Katlama, A. Lazzarin, P. Skinhoj, S. E. Barton. 2001. Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy. Blood 98(12):3406–12.

    PubMed  CAS  Google Scholar 

  75. Grulich, A. E., Y. Li, A. M. McDonald, P. K. Correll, M. G. Law, and J. M. Kaldor. 2001. Decreasing rates of Kaposi's sarcoma and non-Hodgkin's lymphoma in the era of potent combination anti-retroviral therapy. AIDS 15(5):629–33.

    PubMed  CAS  Google Scholar 

  76. Ledergerber, B., A. Telenti, and M. Egger. 1999. Risk of HIV related Kaposi's sarcoma and non-Hodgkin's lymphoma with potent antiretroviral therapy: prospective cohort study. Swiss HIV Cohort Study. BMJ 319(7201):23–4.

    PubMed  CAS  Google Scholar 

  77. Buchbinder, S. P., S. D. Holmberg, S. Scheer, G. Colfax, P. O'Malley, and E. Vittinghoff.1992. Combination antiretroviral therapy and incidence of AIDS-related malignancies. J Acquir Immune Defic Syndr 21(Suppl 1):S23–6.

    Google Scholar 

  78. Jones, J., D. Hanson, M. Dworkin, J. Ward, and H. W. Jaffe. 1992. Effect on antiretroviral therapy on recent trends in selected cancers among HIV-infected persons. Adult/Adolescent Spectrum of HIV Disease Project Group. J Acquir Immune Defic Syndr 21(Suppl 1):S11–7.

    Google Scholar 

  79. Navarro, W. H., and L. D. Kaplan. AIDS-related lymphoproliferative disease. Blood 107(1):13–20.

    Google Scholar 

  80. Roithmann, S., J. M. Tourani, and J. M. Andrieu. 1991. AIDS-associated non-Hodgkin lymphoma. Lancet 338(8771):884–5.

    PubMed  CAS  Google Scholar 

  81. Powles, T., G. Matthews, and M. Bower. 2000. AIDS related systemic non-Hodgkin's lymphoma. Sex Transm Infect 76(5):335–41.

    PubMed  CAS  Google Scholar 

  82. Colomo, L., F. Loong, and S. Rives. 2004. Plasmablastic lymphomas (PBL): diverse lymphomas associated with immunodeficiency and HIV. Paper presented at the Eighth International Conference of Malignancies in AIDS and Other Immunodeficiencies, Abstract 41; 2004.

    Google Scholar 

  83. Chetty, R., N. Hlatswayo, R. Muc, R. Sabaratnam, and K. Gatter. 2003. Plasmablastic lymphoma in HIV+ patients: an expanding spectrum. Histopathology 42(6):605–9.

    PubMed  CAS  Google Scholar 

  84. Schichman, S. A., R. McClure, R. F. Schaefer, and P. Mehta. 2004. HIV and plasmablastic lymphoma manifesting in sinus, testicles, and bones: a further expansion of the disease spectrum. Am J Hematol 77(3):291–5.

    PubMed  Google Scholar 

  85. Lin, O., R. Gerhard, M. C. Zerbini, and J. Teruya-Feldstein. 2005. Cytologic features of plasmablastic lymphoma. Cancer 105(3):139–44.

    PubMed  Google Scholar 

  86. A predictive model for aggressive non-Hodgkin's lymphoma. The International Non-Hodgkin's Lymphoma Prognostic Factors Project. N Engl J Med 329(14):987–94.

    Google Scholar 

  87. Sweetenham, J. W. 2005. Diffuse large B-cell lymphoma: risk stratification and management of relapsed disease. Hematology (Am Soc Hematol Educ Program) 252–9.

    Google Scholar 

  88. Lim, S. T., R. Karim, A. Tulpule, B. N. Nathwani, and A. M. Levine. 2005. Prognostic factors in HIV-related diffuse large-cell lymphoma: before versus after highly active antiretroviral therapy. J Clin Oncol 23(33):8477–82.

    PubMed  Google Scholar 

  89. Chari, A., and L. Kaplan. 2005. Diagnosis and management of non-Hodgkin's lymphoma and Hodgkin's lymphoma. In: Volberding, P. A., J. M. Palefsky, editors. Viral and Immunological Malignancies. 1st ed. Hamilton: BC Decker; 2005, pp. 180–205.

    Google Scholar 

  90. Cheung, M. C., L. Pantanowitz, and B. J. Dezube. 2005. AIDS-related malignancies: emerging challenges in the era of highly active antiretroviral therapy. Oncologist 10(6):412–26.

    PubMed  CAS  Google Scholar 

  91. Lyter, D. W., J. Bryant, R. Thackeray, C. R. Rinaldo, and L. A. Kingsley. 1995. Incidence of human immunodeficiency virus-related and nonrelated malignancies in a large cohort of homosexual men. J Clin Oncol 13(10):2540–6.

    PubMed  CAS  Google Scholar 

  92. Kaplan, L. D., D. J. Straus, M. A. Testa, J. Von Roenn, B. J. Dezube, T. P. Cooley, B. Herndier, D. W. Northfelt, J. Huang, A. Tulpule, and A. M. Levine. 1997. Low-dose compared with standard-dose m-BACOD chemotherapy for non-Hodgkin's lymphoma associated with human immunodeficiency virus infection. National Institute of Allergy and Infectious Diseases AIDS Clinical Trials Group. N Engl J Med 336(23):1641–8.

    Google Scholar 

  93. Sandler, A. S., and L. D. Kaplan. 1996. Diagnosis and management of systemic non-Hodgkin's lymphoma in HIV disease. Hematol Oncol Clin North Am 10(5):1111–24.

    PubMed  CAS  Google Scholar 

  94. Ratner, L., J. Lee, S. Tang, D. Redden, F. Hamzeh, B. Herndier, D. Scadden, L. Kaplan, R. Ambinder, A. Levine, W. Harrington, L. Grochow, C. Flexner, B. Tan, and D. Straus. 2001. Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy. J Clin Oncol 19(8):2171–8.

    PubMed  CAS  Google Scholar 

  95. Vaccher, E., M. Spina, G. di Gennaro, R. Talamini, G. Nasti, O. Schioppa, G. Vultaggio, and U. Tirelli. 2001. Concomitant cyclophosphamide, doxorubicin, vincristine, and prednisone chemotherapy plus highly active antiretroviral therapy in patients with human immunodeficiency virus-related, non-Hodgkin lymphoma. Cancer 91(1):155–63.

    PubMed  CAS  Google Scholar 

  96. Mounier, N., M. Spina, J. Gabarre, et al. AIDS-related non-Hodgkin's lymphoma: final analysis of 485 patients treated with risk-adapted intensive chemotherapy. Blood 2006; 107(10):3832–40.

    Google Scholar 

  97. Sparano, J. A., S. Lee, M. G. Chen, T. Nazeer, A. Einzig, R. F. Ambinder, D. H. Henry, J. Manalo, T. Li, and J. H. Von Roenn. 2004. Phase II trial of infusional cyclophosphamide, doxorubicin, and etoposide in patients with HIV-associated non-Hodgkin's lymphoma: an Eastern Cooperative Oncology Group Trial (E1494). J Clin Oncol 22(8):1491–500.

    PubMed  CAS  Google Scholar 

  98. Bower, M., N. McCall-Peat, N. Ryan, L. Davies, A. M. Young, S. Gupta, M. Nelson, B. Gazzard, and J. Stebbing. 2004. Protease inhibitors potentiate chemotherapy-induced neutropenia. Blood 104(9):2943–6.

    PubMed  CAS  Google Scholar 

  99. Little, R. F., S. Pittaluga, N. Grant, S. M. Steinberg, M. F. Kavlick, H. Mitsuya, G. Franchini, M. Gutierrez, M. Raffeld, E. S. Jaffe, G. Shearer, R. Yarchoan, and W. H. Wilson. 2003. Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology. Blood 101(12):4653–9.

    PubMed  CAS  Google Scholar 

  100. Kaplan, L., J. Lee, and D. Scadden. 2003. No benefit from rituximab in a randomized phase III trial of CHOP with or without rituximab for patients with HIV-associated non-Hodgkin's lymphoma: updated data from AIDS Malignancies Consortium Study 010. Blood 23:1002.

    Google Scholar 

  101. Vilmer, E., A. Rhodes-Feuillette, C. Rabian, M. Benbunan, J. Meletis, A. Devergie, J. H. Bourrhis, J. C. Gluckman, J. C. Chermann, and E. Gluckman E. 1987. Clinical and immunological restoration in patients with AIDS after marrow transplantation, using lymphocyte transfusions from the marrow donor. Transplantation 44(1):25–9.

    Google Scholar 

  102. Davis, K. C., A. Hayward, G. Ozturk, and P. F. Kohler. 1983. Lymphocyte transfusion in case of acquired immunodeficiency syndrome. Lancet 1(8324):599–600.

    PubMed  CAS  Google Scholar 

  103. Hassett, J. M., C. G. Zaroulis, M. L. Greenberg, and F. P. Siegal. 1983. Bone marrow transplantation in AIDS. N Engl J Med 309(11):665.

    PubMed  CAS  Google Scholar 

  104. Holland, H. K., R. Saral, J. J. Rossi, A. D. Donnenberg, W. H. Burns, W. E. Beschorner, H. Farzadegan, R. J. Jones, G. V. Quinnan, G. B. Vogelsang, et al. Allogeneic bone marrow transplantation, zidovudine, and human immunodeficiency virus type 1 (HIV-1) infection. Studies in a patient with non-Hodgkin lymphoma. Ann Intern Med 111(12):973–81.

    Google Scholar 

  105. Gabarre, J., N. Azar, B. Autran, C. Katlama, and V. Leblond. 2000. High-dose therapy and autologous haematopoietic stem-cell transplantation for HIV-1-associated lymphoma. Lancet 355(9209):1071–2.

    PubMed  CAS  Google Scholar 

  106. Krishnan, A., A. Molina, J. Zaia, D. Smith, D. Vasquez, N. Kogut, P. M. Falk, J. Rosenthal, J. Alvarnas, and S. J. Forman. 2005. Durable remissions with autologous stem cell transplantation for high-risk HIV-associated lymphomas. Blood 105(2):874–8.

    PubMed  CAS  Google Scholar 

  107. Re, A., C. Cattaneo, M. Michieli, S. Casari, M. Spina, M. Rupolo, B. Allione, A. Nosari, C. Schiantarelli, M. Vigano, I. Izzi, P. Ferremi, A. Lanfranchi, M. Mazzuccato, G. Carosi, U. Tirelli, and G. Rossi. 2003. High-dose therapy and autologous peripheral-blood stem-cell transplantation as salvage treatment for HIV-associated lymphoma in patients receiving highly active antiretroviral therapy. J Clin Oncol 21(23):4423–7.

    PubMed  CAS  Google Scholar 

  108. Diez-Martin, J., P. Balsalobre, R. Carrion, et al. 2003. Long term survival after autologous stem cell transplant (ASCT) in AIDS related lymphoma patients [abstract 868]. Blood 102:247a.

    Google Scholar 

  109. Molina, A., J. Zaia, and A. Krishnan. 2003. Treatment of human immunodeficiency virus-related lymphoma with haematopoietic stem cell transplantation. Blood Rev 17(4):249–58.

    PubMed  Google Scholar 

  110. Berretta, M., R. Cinelli, F. Martellotta, M. Spina, E. Vaccher, and U. Tirelli. 2003. Therapeutic approaches to AIDS-related malignancies. Oncogene 22(42):6646–59.

    PubMed  CAS  Google Scholar 

  111. Ansell, S. M., and J. O. Armitage. 2006. Management of Hodgkin lymphoma. Mayo Clin Proc 81(3):419–26.

    PubMed  Google Scholar 

  112. Uccini, S., F. Monardo, L. P. Ruco, C. D. Baroni, A. Faggioni, A. M. Agliano, A. Gradilone, V. Manzari, L. Vago, G. Costanzi, et al. 1989. High frequency of Epstein-Barr virus genome in HIV-positive patients with Hodgkin's disease. Lancet 1(8652):1458.

    PubMed  CAS  Google Scholar 

  113. Grulich, A. E., Y. Li, A. McDonald, P. K. Correll, M. G. Law, and J. M. Kaldor. 2002. Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis. AIDS 16(8):1155–61.

    PubMed  Google Scholar 

  114. IARC Working Group on the Evaluation of Carcinogenic Risks to Humans. 1996. Human Immunodeficiency Viruses and Human T-Cell Lymphotropic Viruses, Lyon, France, 1–18 June 1996. IARC Monogr Eval Carcinog Risks Hum 67:1–424.

    Google Scholar 

  115. Glaser, S. L., C. A. Clarke, M. L. Gulley, F. E. Craig, J. A. DiGiuseppe, R. F. Dorfman, R. B. Mann, and R. F. Ambinder. 2003. Population-based patterns of human immunodeficiency virus-related Hodgkin lymphoma in the Greater San Francisco Bay Area, 1988–1998. Cancer 98(2):300–9.

    PubMed  Google Scholar 

  116. Franceschi, S., L. Dal Maso, S. Arniani, P. Crosignani, M. Vercelli, L. Simonato, F. Falcini, R. Zanetti, A. Barchielli, D. Serraino, and G. Rezza. 1998. Risk of cancer other than Kaposi's sarcoma and non-Hodgkin's lymphoma in persons with AIDS in Italy. Cancer and AIDS Registry Linkage Study. Br J Cancer 78(7):966–70.

    PubMed  CAS  Google Scholar 

  117. Spina, M., S. Sandri, and U. Tirelli. 1999. Hodgkin's disease in HIV-infected individuals. Curr Opin Oncol 11(6):522–6.

    PubMed  CAS  Google Scholar 

  118. Spina, M., E. Vaccher, A. Carbone, and U. Tirelli. Neoplastic complications of HIV infection. Ann Oncol 10(11):1271–86.

    Google Scholar 

  119. Doweiko, J., B. J. Dezube, and L. Pantanowitz. 2004. Unusual sites of Hodgkin's lymphoma: CASE 1. HIV-associated Hodgkin's lymphoma of the stomach. J Clin Oncol 22(20):4227–8.

    PubMed  Google Scholar 

  120. Vaccher, E., M. Spina, and U. Tirelli. 2001. Clinical aspects and management of Hodgkin's disease and other tumours in HIV-infected individuals. Eur J Cancer 37(10):1306–15.

    PubMed  CAS  Google Scholar 

  121. Spina, M., M. Berretta, and U. Tirelli. 2003. Hodgkin's disease in HIV. Hematol Oncol Clin North Am 17(3):843–58.

    PubMed  Google Scholar 

  122. Tirelli, U., D. Errante, R. Dolcetti, A. Gloghini, D. Serraino, E. Vaccher, S. Franceschi, M. Boiocchi, and A. Carbone. 1995. Hodgkin's disease and human immunodeficiency virus infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors. J Clin Oncol 13(7):1758–67.

    PubMed  CAS  Google Scholar 

  123. Hoffmann, C., K. U. Chow, E. Wolf, G. Faetkenheuer, H. J. Stellbrink, J. van Lunzen, H. Jaeger, A. Stoehr, A. Plettenberg, J. C. Wasmuth, J. Rockstroh, F. Mosthaf, H. A. Horst, and H. R. Brodt. 2004. Strong impact of highly active antiretroviral therapy on survival in patients with human immunodeficiency virus-associated Hodgkin's disease. Br J Haematol 125(4):455–62.

    PubMed  Google Scholar 

  124. Rubio, R. 1994. Hodgkin's disease associated with human immunodeficiency virus infection. A clinical study of 46 cases. Cooperative Study Group of Malignancies Associated with HIV Infection of Madrid. Cancer 73(9):2400–7.

    PubMed  CAS  Google Scholar 

  125. Ree, H. J., J. A. Strauchen, A. A. Khan, J. E. Gold, J. P. Crowley, H. Kahn, and R. Zalusky. 1991. Human immunodeficiency virus-associated Hodgkin's disease. Clinicopathologic studies of 24 cases and preponderance of mixed cellularity type characterized by the occurrence of fibrohistiocytoid stromal cells. Cancer 67(6):1614–21.

    PubMed  CAS  Google Scholar 

  126. Errante, D., U. Tirelli, R. Gastaldi, D. Milo, A. M. Nosari, G. Rossi, G. Fiorentini, A. Carbone, E. Vaccher, and S. Monfardini. 1994. Combined antineoplastic and antiretroviral therapy for patients with Hodgkin's disease and human immunodeficiency virus infection. A prospective study of 17 patients. The Italian Cooperative Group on AIDS and Tumors (GICAT). Cancer 73(2):437–44.

    PubMed  CAS  Google Scholar 

  127. Tirelli, U., E. Vaccher, V. Zagonel, R. Talamini, D. Bernardi, M. Tavio, A. Gloghini, M. C. Merola, S. Monfardini, and A. Carbone. 1995. CD30 (Ki-1)-positive anaplastic large-cell lymphomas in 13 patients with and 27 patients without human immunodeficiency virus infection: the first comparative clinicopathologic study from a single institution that also includes 80 patients with other human immunodeficiency virus-related systemic lymphomas. J Clin Oncol 13(2):373–80.

    PubMed  CAS  Google Scholar 

  128. Lister, T. A., D. Crowther, S. B. Sutcliffe, E. Glatstein, G. P. Canellos, R. C. Young, S. A. Rosenberg, C. A. Coltman, M. Tubiana. 1989. Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting. J Clin Oncol 7(11):1630–6.

    PubMed  CAS  Google Scholar 

  129. Gerard, L., L. Galicier, E. Boulanger, L. Quint, M. G. Lebrette, E. Mortier, V. Meignin, and E. Oksenhendler. 2003. Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy. AIDS 17(1):81–7.

    PubMed  CAS  Google Scholar 

  130. Johnson, P. W., J. A. Radford, M. H. Cullen, M. R. Sydes, J. Walewski, A. S. Jack, K. A. MacLennan, S. P. Stenning, S. Clawson, P. Smith, D. Ryder, and B. W. Hancock. 2005. Comparison of ABVD and alternating or hybrid multidrug regimens for the treatment of advanced Hodgkin's lymphoma: results of the United Kingdom Lymphoma Group LY09 Trial (ISRCTN97144519). J Clin Oncol 23(36):9208–18.

    PubMed  CAS  Google Scholar 

  131. Levine, A. M., P. Li, T. Cheung, A. Tulpule, J. Von Roenn, B. N. Nathwani, and L. Ratner. 2000. Chemotherapy consisting of doxorubicin, bleomycin, vinblastine, and dacarbazine with granulocyte-colony-stimulating factor in HIV-infected patients with newly diagnosed Hodgkin's disease: a prospective, multi-institutional AIDS clinical trials group study (ACTG 149). J Acquir Immune Defic Syndr 24(5):444–50.

    PubMed  CAS  Google Scholar 

  132. Hartmann, P., U. Rehwald, B. Salzberger, C. Franzen, M. Sieber, A. Wohrmann, and V. Diehl. 2003. BEACOPP therapeutic regimen for patients with Hodgkin's disease and HIV infection. Ann Oncol 14(10):1562–9.

    PubMed  CAS  Google Scholar 

  133. Errante, D., J. Gabarre, A. L. Ridolfo, G. Rossi, A. M. Nosari, C. Gisselbrecht, Y. Kerneis, F. Mazzetti, E. Vaccher, R. Talamini, A. Carbone, and U. Tirelli. 1999. Hodgkin's disease in 35 patients with HIV infection: an experience with epirubicin, bleomycin, vinblastine and prednisone chemotherapy in combination with antiretroviral therapy and primary use of G-CSF. Ann Oncol 10(2):189–95.

    PubMed  CAS  Google Scholar 

  134. Spina, M., J. Gabarre, G. Rossi, M. Fasan, C. Schiantarelli, E. Nigra, M. Mena, A. Antinori, A. Ammassari, R. Talamini, E. Vaccher, G. di Gennaro, and U. Tirelli. 2002. Stanford V regimen and concomitant HAART in 59 patients with Hodgkin disease and HIV infection. Blood 100(6):1984–8.

    PubMed  CAS  Google Scholar 

  135. Biggar, R. J., M. Frisch, and J. J. Goedert. 2000. Risk of cancer in children with AIDS. AIDS-Cancer Match Registry Study Group. JAMA 284(2):205–9.

    PubMed  CAS  Google Scholar 

  136. Chadwick, E. G., E. L. Connor, I. C. Hanson, V. V. Joshi, H. Abu-Farsakh, R. Yogev, G. McSherry, K. McClain, and S. B. Murphy. 1990. Tumors of smooth-muscle origin in HIV-infected children. JAMA 263(23):3182–4.

    PubMed  CAS  Google Scholar 

  137. Levin, T. L., H. M. Adam, K. H. van Hoeven, and H. S. Goldman. 1994. Hepatic spindle cell tumors in HIV positive children. Pediatr Radiol 24(1):78–9.

    PubMed  CAS  Google Scholar 

  138. Granovsky, M. O., B. U. Mueller, H. S. Nicholson, P. S. Rosenberg, and C. S. Rabkin. 1998. Cancer in human immunodeficiency virus-infected children: a case series from the Children's Cancer Group and the National Cancer Institute. J Clin Oncol 16(5):1729–35.

    Google Scholar 

  139. Chiao, E. Y., and S. E. Krown. 2003. Update on non-acquired immunodeficiency syndrome-defining malignancies. Curr Opin Oncol 15(5):389–97.

    PubMed  Google Scholar 

  140. Mueller, B. U. 1999. Cancers in children infected with the human immunodeficiency virus. Oncologist 4(4):309–17.

    PubMed  CAS  Google Scholar 

  141. Miser, J., T. Triche, T. Kinsella, et al. 1997. Other soft tissue sarcomas of childhood. In: Pizzo, P. A., D. G. Poplack, editors. Principles and Practice of Pediatric Oncology. Philadelphia: Lippincott-Raven Publishers; 1997, pp. 865–88.

    Google Scholar 

  142. Moore, P. S., and Y. Chang. 2001. Molecular virology of Kaposi's sarcoma-associated herpesvirus. Philos Trans R Soc Lond B Biol Sci 356(1408):499–516.

    PubMed  CAS  Google Scholar 

  143. Chang, Y., E. Cesarman, M. S. Pessin, F. Lee, J. Culpepper, D. M. Knowles, and P. S. Moore. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 266(5192):1865–9.

    Google Scholar 

  144. Aoki, Y., and G. Tosato. 2003. Pathogenesis and manifestations of human herpesvirus-8-associated disorders. Semin Hematol 40(2):143–53.

    PubMed  Google Scholar 

  145. Schwartz, E. J., R. F. Dorfman, and S. Kohler. 2003. Human herpesvirus-8 latent nuclear antigen-1 expression in endemic Kaposi sarcoma: an immunohistochemical study of 16 cases. Am J Surg Pathol 27(12):1546–50.

    PubMed  Google Scholar 

  146. Aoki, Y., and G. Tosato. 2003. Targeted inhibition of angiogenic factors in AIDS-related disorders. Curr Drug Targets Infect Disord 3(2):115–28.

    PubMed  CAS  Google Scholar 

  147. Soulier, J., L. Grollet, E. Oksenhendler, P. Cacoub, D. Cazals-Hatem, P. Babinet, M. F. d'Agay, J. P. Clauvel, M. Raphael, L. Degos, et al. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in multicentric Castleman's disease. Blood 86(4):1276–80.

    PubMed  CAS  Google Scholar 

  148. Chadburn, A., E. Cesarman, R. G. Nador, Y. F. Liu, and D. M. Knowles. 1997. Kaposi's sarcoma-associated herpesvirus sequences in benign lymphoid proliferations not associated with human immunodeficiency virus. Cancer 80(4):788–97.

    PubMed  CAS  Google Scholar 

  149. Oksenhendler, E., G. Carcelain, Y. Aoki, E. Boulanger, A. Maillard, J. P. Clauvel, and F. Agbalika. 2000. High levels of human herpesvirus 8 viral load, human interleukin-6, interleukin-10, and C reactive protein correlate with exacerbation of multicentric castleman disease in HIV-infected patients. Blood 96(6):2069–73.

    PubMed  CAS  Google Scholar 

  150. Cesarman, E., Y. Chang, P. S. Moore, J. W. Said, and D. M. Knowles. 1995. Kaposi's sarcoma-associated herpesvirus-like DNA sequences in AIDS-related body-cavity-based lymphomas. N Engl J Med 332(18):1186–91.

    PubMed  CAS  Google Scholar 

  151. Iscovich, J., P. Boffetta, S. Franceschi, E. Azizi, and R. Sarid. 2000. Classic Kaposi sarcoma: epidemiology and risk factors. Cancer 88(3):500–17.

    PubMed  CAS  Google Scholar 

  152. Cook-Mozaffari, P., R. Newton, V. Beral, and D. P. Burkitt. 1998. The geographical distribution of Kaposi's sarcoma and of lymphomas in Africa before the AIDS epidemic. Br J Cancer 78(11):1521–8.

    PubMed  CAS  Google Scholar 

  153. Friedman-Kien, A. E., and B. R. Saltzman. 1990. Clinical manifestations of classical, endemic African, and epidemic AIDS-associated Kaposi's sarcoma. J Am Acad Dermatol 22(6 Pt 2):1237–50.

    PubMed  CAS  Google Scholar 

  154. Siegel, J. H., R. Janis, J. C. Alper, H. Schutte, L. Robbins, and M. D. Blaufox. 1969. Disseminated visceral Kaposi's sarcoma. Appearance after human renal homograft operation. JAMA 207(8):1493–6.

    PubMed  CAS  Google Scholar 

  155. Penn, I. 1979. Kaposi's sarcoma in organ transplant recipients: report of 20 cases. Transplantation 27(1):8–11.

    PubMed  CAS  Google Scholar 

  156. Friedman-Kien, A. E. 1981. Disseminated Kaposi's sarcoma syndrome in young homosexual men. J Am Acad Dermatol 5(4):468–71.

    PubMed  CAS  Google Scholar 

  157. Hengge, U. R., T. Ruzicka, S. K. Tyring, M. Stuschke, M. Roggendorf, R. A. Schwartz, and S. Seeber. 2002. Update on Kaposi's sarcoma and other HHV8 associated diseases. Part 1: epidemiology, environmental predispositions, clinical manifestations, and therapy. Lancet Infect Dis 2(5):281–92.

    PubMed  Google Scholar 

  158. Frisch, M., R. J. Biggar, E. A. Engels, and J. J. Goedert. 2001. Association of cancer with AIDS-related immunosuppression in adults. JAMA 285(13):1736–45.

    PubMed  CAS  Google Scholar 

  159. Kaplan, L. D., and D. W. Northfelt. 1997. Malignancies associated with AIDS. In: Sande, M. A., P. A. Volberding, editors. The Medical Management of AIDS. Philadelphia: WB Saunders; 1997, pp. 413–22.

    Google Scholar 

  160. Friedman, S. L., T. L. Wright, and D. F. Altman. 1985. Gastrointestinal Kaposi's sarcoma in patients with acquired immunodeficiency syndrome. Endoscopic and autopsy findings. Gastroenterology 89(1):102–8.

    PubMed  CAS  Google Scholar 

  161. Mitchell, D. M., M. McCarty, J. Fleming, and F. M. Moss. 1992. Bronchopulmonary Kaposi's sarcoma in patients with AIDS. Thorax 47(9):726–9.

    PubMed  CAS  Google Scholar 

  162. Renwick, N., T. Halaby, G. J. Weverling, N. H. Dukers, G. R. Simpson, R. A. Coutinho, J. M. Lange, T. F. Schulz, and J. Goudsmit. 1998. Seroconversion for human herpesvirus 8 during HIV infection is highly predictive of Kaposi's sarcoma. AIDS 12(18):2481–8.

    PubMed  CAS  Google Scholar 

  163. Jacobson, L. P., F. J. Jenkins, G. Springer, A. Munoz, K. V. Shah, J. Phair, Z. Zhang, and H. Armenian. 2000. Interaction of human immunodeficiency virus type 1 and human herpesvirus type 8 infections on the incidence of Kaposi's sarcoma. J Infect Dis 181(6):1940–9.

    PubMed  CAS  Google Scholar 

  164. Engels, E. A., R. J. Biggar, V. A. Marshall, M. A. Walters, C. J. Gamache, D. Whitby, and J. J. Goedert. 2003. Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi's sarcoma. AIDS 17(12):1847–51.

    PubMed  Google Scholar 

  165. Newton, R., J. Ziegler, D. Bourboulia, D. Casabonne, V. Beral, E. Mbidde, L. Carpenter, D. M. Parkin, H. Wabinga, S. Mbulaiteye, H. Jaffe, R. Weiss, and C. Boshoff. Infection with Kaposi's sarcoma-associated herpesvirus (KSHV) and human immunodeficiency virus (HIV) in relation to the risk and clinical presentation of Kaposi's sarcoma in Uganda. Br J Cancer 89(3):502–4.

    Google Scholar 

  166. Verma, S. C., and E. S. Robertson. 2003. Molecular biology and pathogenesis of Kaposi sarcoma-associated herpesvirus. FEMS Microbiol Lett 222(2):155–63.

    PubMed  CAS  Google Scholar 

  167. Dourmishev, L. A., A. L. Dourmishev, D. Palmeri, R. A. Schwartz, D. M. Lukac. 2003. Molecular genetics of Kaposi's sarcoma-associated herpesvirus (human herpesvirus-8) epidemiology and pathogenesis. Microbiol Mol Biol Rev 67(2):175–212, table of contents.

    Google Scholar 

  168. Tirelli, U., D. Bernardi, M. Spina, and E. Vaccher. 1997. AIDS-related tumors: integrating antiviral and anticancer therapy. Crit Rev Oncol Hematol 41(3):299–315.

    Google Scholar 

  169. Nicholas, J., V. R. Ruvolo, W. H. Burns, G. Sandford, X. Wan, D. Ciufo, S. B. Hendrickson, H. G. Guo, G. S. Hayward, and M. S. Reitz. 1997. Kaposi's sarcoma-associated human herpesvirus-8 encodes homologues of macrophage inflammatory protein-1 and interleukin-6. Nat Med 3(3):287–92.

    PubMed  CAS  Google Scholar 

  170. Bais, C., B. Santomasso, O. Coso, L. Arvanitakis, E. G. Raaka, J. S. Gutkind, A. S. Asch, E. Cesarman, M. C. Gershengorn, and E. A. Mesri. 1998. G-protein-coupled receptor of Kaposi's sarcoma-associated herpesvirus is a viral oncogene and angiogenesis activator. Nature 391(6662):86–9.

    PubMed  CAS  Google Scholar 

  171. Uccini, S., S. Scarpino, F. Ballarini, A. Soriani, M. Chilosi, M. A. Montesu, M. V. Masala, F. Cottoni, and L. Ruco. 2003. In situ study of chemokine and chemokine-receptor expression in Kaposi sarcoma. Am J Dermatopathol 25(5):377–83.

    PubMed  Google Scholar 

  172. Deregibus, M. C., V. Cantaluppi, S. Doublier, M. F. Brizzi, I. Deambrosis, A. Albini, and G. Camussi. 2002. HIV-1-Tat protein activates phosphatidylinositol 3-kinase/AKT-dependent survival pathways in Kaposi's sarcoma cells. J Biol Chem 277(28):25195–202.

    PubMed  CAS  Google Scholar 

  173. Ensoli, B., G. Barillari, S. Z. Salahuddin, R. C. Gallo, and F. Wong-Staal. 1990. Tat protein of HIV-1 stimulates growth of cells derived from Kaposi's sarcoma lesions of AIDS patients. Nature 345(6270):84–6.

    PubMed  CAS  Google Scholar 

  174. Barillari, G., and B. Ensoli. 2002. Angiogenic effects of extracellular human immunodeficiency virus type 1 Tat protein and its role in the pathogenesis of AIDS-associated Kaposi's sarcoma. Clin Microbiol Rev 15(2):310–26.

    PubMed  CAS  Google Scholar 

  175. Impola, U., M. A. Cuccuru, M. V. Masala, L. Jeskanen, F. Cottoni, and U. Saarialho-Kere. 2003. Preliminary communication: matrix metalloproteinases in Kaposi's sarcoma. Br J Dermatol 149(4):905–7.

    PubMed  CAS  Google Scholar 

  176. Lafrenie, R. M., L. M. Wahl, J. S. Epstein, I. K. Hewlett, K. M. Yamada, and S. Dhawan. 1996. HIV-1-Tat modulates the function of monocytes and alters their interactions with microvessel endothelial cells. A mechanism of HIV pathogenesis. J Immunol 156(4):1638–45.

    PubMed  CAS  Google Scholar 

  177. Mocroft, A., O. Kirk, N. Clumeck, P. Gargalianos-Kakolyris, H. Trocha, N. Chentsova, F. Antunes, H. J. Stellbrink, A. N. Phillips, and J. D. Lundgren. 2004. The changing pattern of Kaposi sarcoma in patients with HIV, 1994–2003: the EuroSIDA Study. Cancer 100(12):2644–54.

    PubMed  Google Scholar 

  178. Jones, J. L., D. L. Hanson, M. S. Dworkin, and H. W. Jaffe. 2000. Incidence and trends in Kaposi's sarcoma in the era of effective antiretroviral therapy. J Acquir Immune Defic Syndr 24(3):270–4.

    PubMed  CAS  Google Scholar 

  179. Krown, S. E., M. A. Testa, and J. Huang. 1997. AIDS-related Kaposi's sarcoma: prospective validation of the AIDS Clinical Trials Group staging classification. AIDS Clinical Trials Group Oncology Committee. J Clin Oncol 15(9):3085–92.

    PubMed  CAS  Google Scholar 

  180. Beral, V., T. A. Peterman, R. L. Berkelman, and H. W. Jaffe. 1990. Kaposi's sarcoma among persons with AIDS: a sexually transmitted infection? Lancet 335(8682):123–8.

    PubMed  CAS  Google Scholar 

  181. Hoover, D. R., C. Black, L. P. Jacobson, O. Martinez-Maza, D. Seminara, A. Saah, J. Von Roenn, R. Anderson, and H. K. Armenian. 1993. Epidemiologic analysis of Kaposi's sarcoma as an early and later AIDS outcome in homosexual men. Am J Epidemiol 138(4):266–78.

    PubMed  CAS  Google Scholar 

  182. Campbell, T. B., M. Borok, I. E. White, I. Gudza, B. Ndemera, A. Taziwa, A. Weinberg, and L. Gwanzura. 2003. Relationship of Kaposi sarcoma (KS)-associated herpesvirus viremia and KS disease in Zimbabwe. Clin Infect Dis 36(9):1144–51.

    PubMed  Google Scholar 

  183. Wabinga, H. R., D. M. Parkin, F. Wabwire-Mangen, and J. W. Mugerwa. 1993. Cancer in Kampala, Uganda, in 1989–91: changes in incidence in the era of AIDS. Int J Cancer 54(1):26–36.

    PubMed  CAS  Google Scholar 

  184. Chokunonga, E., L. M. Levy, M. T. Bassett, B. G. Mauchaza, D. B. Thomas, and D. M. Parkin. 2000. Cancer incidence in the African population of Harare, Zimbabwe: second results from the cancer registry 1993–1995. Int J Cancer 85(1):54–9.

    PubMed  CAS  Google Scholar 

  185. Dezube, B. J. 2000. Acquired immunodeficiency syndrome-related Kaposi's sarcoma: clinical features, staging, and treatment. Semin Oncol 27(4):424–30.

    PubMed  CAS  Google Scholar 

  186. Nasti, G., R. Talamini, A. Antinori, F. Martellotta, G. Jacchetti, F. Chiodo, G. Ballardini, L. Stoppini, G. Di Perri, M. Mena, M. Tavio, E. Vaccher, A. D'Arminio Monforte, and U. Tirelli. 2003. AIDS-related Kaposi's Sarcoma: evaluation of potential new prognostic factors and assessment of the AIDS Clinical Trial Group Staging System in the Haart Era – the Italian Cooperative Group on AIDS and Tumors and the Italian Cohort of Patients Naive From Antiretrovirals. J Clin Oncol 21(15):2876–82.

    PubMed  Google Scholar 

  187. Dezube, B. J., L. Pantanowitz, and D. M. Aboulafia. 2004. Management of AIDS-related Kaposi sarcoma: advances in target discovery and treatment. AIDS Read 14(5):236–8, 243–4, 251–3.

    Google Scholar 

  188. Danzig, J. B., L. J. Brandt, J. F. Reinus, and R. S. Klein. 1991. Gastrointestinal malignancy in patients with AIDS. Am J Gastroenterol 86(6):715–8.

    PubMed  CAS  Google Scholar 

  189. Aboulafia, D. M. 2000. The epidemiologic, pathologic, and clinical features of AIDS-associated pulmonary Kaposi's sarcoma. Chest 117(4):1128–45.

    PubMed  CAS  Google Scholar 

  190. Gruden, J. F., L. Huang, W. R. Webb, G. Gamsu, P. C. Hopewell, and D. M. Sides. 1995. AIDS-related Kaposi sarcoma of the lung: radiographic findings and staging system with bronchoscopic correlation. Radiology 195(2):545–52.

    PubMed  CAS  Google Scholar 

  191. Boudreaux, A. A., L. L. Smith, C. D. Cosby, M. M. Bason, J. W. Tappero, and B. G. Berger. 1993. Intralesional vinblastine for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. A clinical trial to evaluate efficacy and discomfort associated with infection. J Am Acad Dermatol 28(1):61–5.

    PubMed  CAS  Google Scholar 

  192. Pluda, J. M., S. Broder, and R. Yarchoan. 1992. Therapy of AIDS and AIDS-associated neoplasms. Cancer Chemother Biol Response Modif 13:404–39.

    PubMed  CAS  Google Scholar 

  193. Cooper, J. S., A. D. Steinfeld, and I. Lerch. 1991. Intentions and outcomes in the radiotherapeutic management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 20(3):419–22.

    PubMed  CAS  Google Scholar 

  194. de Wit, R., W. G. Smit, K. H. Veenhof, P. J. Bakker, F. Oldenburger, and D. G. Gonzalez. 1990. Palliative radiation therapy for AIDS-associated Kaposi's sarcoma by using a single fraction of 800 cGy. Radiother Oncol 19(2):131–6.

    PubMed  Google Scholar 

  195. Northfelt, D. W., B. J. Dezube, J. A. Thommes, B. J. Miller, M. A. Fischl, A. Friedman-Kien, L. D. Kaplan, C. Du Mond, R. D. Mamelok, and D. H. Henry. 1998. Pegylated-liposomal doxorubicin versus doxorubicin, bleomycin, and vincristine in the treatment of AIDS-related Kaposi's sarcoma: results of a randomized phase III clinical trial. J Clin Oncol 16(7):2445–51.

    PubMed  CAS  Google Scholar 

  196. Stewart, S., H. Jablonowski, F. D. Goebel, K. Arasteh, M. Spittle, A. Rios, D. Aboulafia, J. Galleshaw, B. J. Dezube. 1998. Randomized comparative trial of pegylated liposomal doxorubicin versus bleomycin and vincristine in the treatment of AIDS-related Kaposi's sarcoma. International Pegylated Liposomal Doxorubicin Study Group. J Clin Oncol 16(2):683–91.

    PubMed  CAS  Google Scholar 

  197. Gill, P. S., J. Wernz, D. T. Scadden, P. Cohen, G. M. Mukwaya, J. H. von Roenn, M. Jacobs, S. Kempin, I. Silverberg, G. Gonzales, M. U. Rarick, A. M. Myers, F. Shepherd, C. Sawka, M. C. Pike, and M. E. Ross. 1996. Randomized phase III trial of liposomal daunorubicin versus doxorubicin, bleomycin, and vincristine in AIDS-related Kaposi's sarcoma. J Clin Oncol 14(8):2353–64.

    PubMed  CAS  Google Scholar 

  198. Welles, L., M. W. Saville, J. Lietzau, J. M. Pluda, K. M. Wyvill, I. Feuerstein, W. D. Figg, R. Lush, J. Odom, W. H. Wilson, M. T. Fajardo, R. W. Humphrey, E. Feigal, D. Tuck, S. M. Steinberg, S. Broder, and R. Yarchoan. 1998. Phase II trial with dose titration of paclitaxel for the therapy of human immunodeficiency virus-associated Kaposi's sarcoma. J Clin Oncol 16(3):1112–21.

    PubMed  CAS  Google Scholar 

  199. Gill, P. S., A. Tulpule, B. M. Espina, S. Cabriales, J. Bresnahan, M. Ilaw, S. Louie, N. F. Gustafson, M. A. Brown, C. Orcutt, B. Winograd, and D. T. Scadden. 1999. Paclitaxel is safe and effective in the treatment of advanced AIDS-related Kaposi's sarcoma. J Clin Oncol 17(6):1876–83.

    PubMed  CAS  Google Scholar 

  200. Tulpule, A., J. Groopman, M. W. Saville, W. Harrington, Jr., A. Friedman-Kien, B. M. Espina, C. Garces, L. Mantelle, K. Mettinger, D. T. Scadden, and P. S. Gill. 2002. Multicenter trial of low-dose paclitaxel in patients with advanced AIDS-related Kaposi sarcoma. Cancer 95(1):147–54.

    PubMed  CAS  Google Scholar 

  201. Stebbing, J., A. Wildfire, S. Portsmouth, T. Powles, C. Thirlwell, P. Hewitt, M. Nelson, S. Patterson, S. Mandalia, F. Gotch, B. G. Gazzard, and M. Bower. 2003. Paclitaxel for anthracycline-resistant AIDS-related Kaposi's sarcoma: clinical and angiogenic correlations. Ann Oncol 14(11):1660–6.

    PubMed  CAS  Google Scholar 

  202. Nasti, G., D. Errante, S. Santarossa, E. Vaccher, and U. Tirelli. 1999. A risk and benefit assessment of treatment for AIDS-related Kaposi's sarcoma. Drug Saf 20(5):403–25.

    PubMed  CAS  Google Scholar 

  203. Bundow, D., and D. M. Aboulafia. 2004. Potential drug interaction with paclitaxel and highly active antiretroviral therapy in two patients with AIDS-associated Kaposi sarcoma. Am J Clin Oncol 27(1):81–4.

    PubMed  Google Scholar 

  204. Robles, R., D. Lugo, L. Gee, and M. A. Jacobson. 1999. Effect of antiviral drugs used to treat cytomegalovirus end-organ disease on subsequent course of previously diagnosed Kaposi's sarcoma in patients with AIDS. J Acquir Immune Defic Syndr Hum Retrovirol 20(1):34–8.

    PubMed  CAS  Google Scholar 

  205. Martin, D. F., B. D. Kuppermann, R. A. Wolitz, A. G. Palestine, H. Li, and C. A. Robinson. 1999. Oral ganciclovir for patients with cytomegalovirus retinitis treated with a ganciclovir implant. Roche Ganciclovir Study Group. N Engl J Med 340(14):1063–70.

    PubMed  CAS  Google Scholar 

  206. Little, R. F., F. Merced-Galindez, K. Staskus, D. Whitby, Y. Aoki, R. Humphrey, J. M. Pluda, V. Marshall, M. Walters, L. Welles, I. R. Rodriguez-Chavez, S. Pittaluga, G. Tosato, and R. Yarchoan. 2003. A pilot study of cidofovir in patients with kaposi sarcoma. J Infect Dis 187(1):149–53.

    PubMed  CAS  Google Scholar 

  207. Klass, C. M., and M. K. Offermann. 2005. Targeting human herpesvirus-8 for treatment of Kaposi's sarcoma and primary effusion lymphoma. Curr Opin Oncol 17(5):447–55.

    PubMed  CAS  Google Scholar 

  208. Dezube, B. J., J. H. Von Roenn, J. Holden-Wiltse, T. W. Cheung, S. C. Remick, T. P. Cooley, J. Moore, J. P. Sommadossi, S. L. Shriver, C. W. Suckow, and P. S. Gill. 1998. Fumagillin analog in the treatment of Kaposi's sarcoma: a phase I AIDS Clinical Trial Group study. AIDS Clinical Trial Group No. 215 Team. J Clin Oncol 16(4):1444–9.

    PubMed  CAS  Google Scholar 

  209. Little, R. F., K. M. Wyvill, J. M. Pluda, L. Welles, V. Marshall, W. D. Figg, F. M. Newcomb, G. Tosato, E. Feigal, S. M. Steinberg, D. Whitby, J. J. Goedert, and R. Yarchoan. 2000. Activity of thalidomide in AIDS-related Kaposi's sarcoma. J Clin Oncol 18(13):2593–602.

    PubMed  CAS  Google Scholar 

  210. Cianfrocca, M., T. P. Cooley, J. Y. Lee, M. A. Rudek, D. T. Scadden, L. Ratner, J. M. Pluda, W. D. Figg, S. E. Krown, and B. J. Dezube. Matrix metalloproteinase inhibitor COL-3 in the treatment of AIDS-related Kaposi's sarcoma: a phase I AIDS malignancy consortium study. J Clin Oncol 20(1):153–9.

    Google Scholar 

  211. Koon, H. B., G. J. Bubley, L. Pantanowitz, D. Masiello, B. Smith, K. Crosby, J. Proper, W. Weeden, T. E. Miller, P. Chatis, M. J. Egorin, S. R. Tahan, and B. J. Dezube. 2005. Imatinib-induced regression of AIDS-related Kaposi's sarcoma. J Clin Oncol 23(5):982–9.

    PubMed  CAS  Google Scholar 

  212. Noy, A., D. T. Scadden, J. Lee, B. J. Dezube, D. Aboulafia, A. Tulpule, S. Walmsley, and P. Gill. 2005. Angiogenesis inhibitor IM862 is ineffective against AIDS-Kaposi's sarcoma in a phase III trial, but demonstrates sustained, potent effect of highly active antiretroviral therapy: from the AIDS Malignancy Consortium and IM862 Study Team. J Clin Oncol 23(5):990–8.

    PubMed  CAS  Google Scholar 

  213. Sturzl, M., W. K. Roth, N. H. Brockmeyer, C. Zietz, B. Speiser, and P. H. Hofschneider. 1992. Expression of platelet-derived growth factor and its receptor in AIDS-related Kaposi sarcoma in vivo suggests paracrine and autocrine mechanisms of tumor maintenance. Proc Natl Acad Sci USA 89(15):7046–50.

    PubMed  CAS  Google Scholar 

  214. Moses, A. V., M. A. Jarvis, C. Raggo, Y. C. Bell, R. Ruhl, B. G. Luukkonen, D. J. Griffith, C. L. Wait, B. J. Druker, M. C. Heinrich, J. A. Nelson, and K. Fruh. 2002. Kaposi's sarcoma-associated herpesvirus-induced upregulation of the c-kit proto-oncogene, as identified by gene expression profiling, is essential for the transformation of endothelial cells. J Virol 76(16):8383–99.

    PubMed  CAS  Google Scholar 

  215. Scadden, D. T. 2003. AIDS-related malignancies. Annu Rev Med 54:285–303.

    PubMed  CAS  Google Scholar 

  216. Noy, A. 2003. Update in Kaposi sarcoma. Curr Opin Oncol 15(5):379–81.

    PubMed  Google Scholar 

  217. Sgadari, C., P. Monini, G. Barillari, and B. Ensoli. 2003. Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth. Lancet Oncol 4(9):537–47.

    PubMed  CAS  Google Scholar 

  218. Bower, M., P. Fox, K. Fife, J. Gill, M. Nelson, and B. Gazzard. 1999. Highly active anti-retroviral therapy (HAART) prolongs time to treatment failure in Kaposi's sarcoma. AIDS 13(15):2105–11.

    PubMed  CAS  Google Scholar 

  219. Lebbe, C., L. Blum, C. Pellet, G. Blanchard, O. Verola, P. Morel, O. Danne, and F. Calvo. 1998. Clinical and biological impact of antiretroviral therapy with protease inhibitors on HIV-related Kaposi's sarcoma. AIDS 12(7):F45–9.

    PubMed  CAS  Google Scholar 

  220. Tavio, M., G. Nasti, M. Spina, D. Errante, E. Vaccher, and U. Tirelli. 1998. Highly active antiretroviral therapy in HIV-related Kaposi's sarcoma. Ann Oncol 9(8):923.

    PubMed  CAS  Google Scholar 

  221. Levine, A. M., and A. Tulpule. 2001. Clinical aspects and management of AIDS-related Kaposi's sarcoma. Eur J Cancer 37(10):1288–95.

    PubMed  CAS  Google Scholar 

  222. Nasti, G., F. Martellotta, M. Berretta, M. Mena, M. Fasan, G. Di Perri, R. Talamini, G. Pagano, M. Montroni, R. Cinelli, E. Vaccher, A. D'Arminio Monforte, and U. Tirelli. 2003. Impact of highly active antiretroviral therapy on the presenting features and outcome of patients with acquired immunodeficiency syndrome-related Kaposi sarcoma. Cancer 98(11):2440–6.

    PubMed  Google Scholar 

  223. Tam, H. K., Z. F. Zhang, L. P. Jacobson, J. B. Margolick, J. S. Chmiel, C. Rinaldo, and R. Detels. 2002. Effect of highly active antiretroviral therapy on survival among HIV-infected men with Kaposi sarcoma or non-Hodgkin lymphoma. Int J Cancer 98(6):916–22.

    PubMed  CAS  Google Scholar 

  224. Jung, C., J. R. Bogner, and F. Goebel. 1998. Resolution of severe Kaposi's sarcoma after initiation of antiretroviral triple therapy. Eur J Med Res 3(9):439–42.

    PubMed  CAS  Google Scholar 

  225. Castleman, B., L. Iverson, and V. P. Menendez. 1956. Localized mediastinal lymphnode hyperplasia resembling thymoma. Cancer 9(4):822–30.

    PubMed  CAS  Google Scholar 

  226. Herrada, J., F. Cabanillas, L. Rice, J. Manning, and W. Pugh. 1998. The clinical behavior of localized and multicentric Castleman disease. Ann Intern Med 128(8):657–62.

    PubMed  CAS  Google Scholar 

  227. Leibetseder, F., and J. Thurner. 1973. Angiofollicular lymph node hyperplasia (onion-skin lymphoma). Med Klin 68(24):817–20.

    PubMed  CAS  Google Scholar 

  228. Gaba, A. R., R. S. Stein, D. L. Sweet, and D. Variakojis. 1978. Multicentric giant lymph node hyperplasia. Am J Clin Pathol 69(1):86–90.

    PubMed  CAS  Google Scholar 

  229. Frizzera, G., B. A. Peterson, E. D. Bayrd, and A. Goldman. 1985. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease: clinical findings and clinicopathologic correlations in 15 patients. J Clin Oncol 3(9):1202–16.

    PubMed  CAS  Google Scholar 

  230. Peterson, B. A., and G. Frizzera G. 1993. Multicentric Castleman's disease. Semin Oncol 20(6):636–47.

    Google Scholar 

  231. Lachant, N. A., N. C. Sun, L. A. Leong, R. S. Oseas, and H. E. Prince. 1985. Multicentric angiofollicular lymph node hyperplasia (Castleman's disease) followed by Kaposi's sarcoma in two homosexual males with the acquired immunodeficiency syndrome (AIDS). Am J Clin Pathol 83(1):27–33.

    PubMed  CAS  Google Scholar 

  232. Oksenhendler, E., E. Boulanger, L. Galicier, M. Q. Du, N. Dupin, T. C. Diss, R. Hamoudi, M. T. Daniel, F. Agbalika, C. Boshoff, J. P. Clauvel, P. G. Isaacson, and V. Meignin. 2002. High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease. Blood 99(7):2331–6.

    PubMed  CAS  Google Scholar 

  233. Russo, J. J., R. A. Bohenzky, M. C. Chien, J. Chen, M. Yan, D. Maddalena, J. P. Parry, D. Peruzzi, I. S. Edelman, Y. Chang, and P. S. Moore. 1996. Nucleotide sequence of the Kaposi sarcoma-associated herpesvirus (HHV8). Proc Natl Acad Sci USA 93(25):14862–7.

    PubMed  CAS  Google Scholar 

  234. Foussat, A., R. Fior, T. Girard, F. Boue, J. Wijdenes, P. Galanaud, and D. Emilie. 1999. Involvement of human interleukin-6 in systemic manifestations of human herpesvirus type 8-associated multicentric Castleman's disease. AIDS 13(1):150–2.

    PubMed  CAS  Google Scholar 

  235. Drexler, H. G., C. Meyer, G. Gaidano, and A. Carbone. 1999. Constitutive cytokine production by primary effusion (body cavity-based) lymphoma-derived cell lines. Leukemia 13(4):634–40.

    PubMed  CAS  Google Scholar 

  236. Dupin, N., T. L. Diss, P. Kellam, M. Tulliez, M. Q. Du, D. Sicard, R. A. Weiss, P. G. Isaacson, and C. Boshoff. 2000. HHV-8 is associated with a plasmablastic variant of Castleman disease that is linked to HHV-8-positive plasmablastic lymphoma. Blood 95(4):1406–12.

    PubMed  CAS  Google Scholar 

  237. Oksenhendler, E., M. Duarte, J. Soulier, P. Cacoub, Y. Welker, J. Cadranel, D. Cazals-Hatem, B. Autran, J. P. Clauvel, and M. Raphael. 1996. Multicentric Castleman's disease in HIV infection: a clinical and pathological study of 20 patients. AIDS 10(1):61–7.

    PubMed  CAS  Google Scholar 

  238. Du, M. Q., H. Liu, T. C. Diss, H. Ye, R. A. Hamoudi, N. Dupin, V. Meignin, E. Oksenhendler, C. Boshoff, and P. G. Isaacson. 2001. Kaposi sarcoma-associated herpesvirus infects monotypic (IgM lambda) but polyclonal naive B cells in Castleman disease and associated lymphoproliferative disorders. Blood 97(7):2130–6.

    PubMed  CAS  Google Scholar 

  239. Aaron, L., O. Lidove, C. Yousry, L. Roudiere, B. Dupont, and J. P. Viard. 2002. Human herpesvirus 8-positive Castleman disease in human immunodeficiency virus-infected patients: the impact of highly active antiretroviral therapy. Clin Infect Dis 35(7):880–2.

    PubMed  Google Scholar 

  240. Frizzera, G., P. M. Banks, G. Massarelli, and J. Rosai. 1983. A systemic lymphoproliferative disorder with morphologic features of Castleman's disease. Pathological findings in 15 patients. Am J Surg Pathol 7(3):211–31.

    PubMed  CAS  Google Scholar 

  241. Kim, J. H., T. G. Jun, S. W. Sung, Y. S. Shim, S. K. Han, Y. W. Kim, C. G. Yoo, J. W. Seo, and J. R. Rho. 1995. Giant lymph node hyperplasia (Castleman's disease) in the chest. Ann Thorac Surg 59(5):1162–5.

    PubMed  CAS  Google Scholar 

  242. Loi, S., D. Goldstein, K. Clezy, S. T. Milliken, J. Hoy, and M. Chipman. 2004. Castleman's disease and HIV infection in Australia. HIV Med 5(3):157–62.

    PubMed  CAS  Google Scholar 

  243. Seirafi, P. A., E. Ferguson, F. H. Edwards. 2003. Thoracoscopic resection of Castleman disease: case report and review. Chest 123(1):280–2.

    Google Scholar 

  244. Chronowski, G. M., C. S. Ha, R. B. Wilder, F. Cabanillas, J. Manning, and J. D. Cox. 2001. Treatment of unicentric and multicentric Castleman disease and the role of radiotherapy. Cancer 92(3):670–6.

    PubMed  CAS  Google Scholar 

  245. Bowne, W. B., J. J. Lewis, D. A. Filippa, R. Niesvizky, A. D. Brooks, M. E. Burt, and M. F. Brennan. 1999. The management of unicentric and multicentric Castleman's disease: a report of 16 cases and a review of the literature. Cancer 85(3):706–17.

    PubMed  CAS  Google Scholar 

  246. Scott, D., L. Cabral, and W. J. Harrington, Jr. 2001. Treatment of HIV-associated multicentric Castleman's disease with oral etoposide. Am J Hematol 66(2):148–50.

    PubMed  CAS  Google Scholar 

  247. Casper, C., W. G. Nichols, M. L. Huang, L. Corey, and A. Wald. 2004. Remission of HHV-8 and HIV-associated multicentric Castleman disease with ganciclovir treatment. Blood 103(5):1632–4.

    PubMed  CAS  Google Scholar 

  248. Senanayake, S., J. Kelly, A. Lloyd, Z. Waliuzzaman, D. Goldstein, and W. Rawlinson. 2003. Multicentric Castleman's disease treated with antivirals and immunosuppressants. J Med Virol 71(3):399–403.

    PubMed  Google Scholar 

  249. Marcelin, A. G., L. Aaron, C. Mateus, E. Gyan, I. Gorin, J. P. Viard, V. Calvez, and N. Dupin. Rituximab therapy for HIV-associated Castleman disease. Blood 102(8):2786–8.

    Google Scholar 

  250. Corbellino, M., G. Bestetti, C. Scalamogna, S. Calattini, M. Galazzi, L. Meroni, D. Manganaro, M. Fasan, M. Moroni, M. Galli, and C. Parravicini. 2001. Long-term remission of Kaposi sarcoma-associated herpesvirus-related multicentric Castleman disease with anti-CD20 monoclonal antibody therapy. Blood 98(12):3473–5.

    PubMed  CAS  Google Scholar 

  251. Kumari, P., G. P. Schechter, N. Saini, and D. A. Benator. 2003. Successful treatment of human immunodeficiency virus-related Castleman's disease with interferon-alpha. Clin Infect Dis 31(2):602–4.

    Google Scholar 

  252. Nord, J. A., and D. Karter. 2003. Low dose interferon-alpha therapy for HIV-associated multicentric Castleman's disease. Int J STD AIDS 14(1):61–2.

    PubMed  CAS  Google Scholar 

  253. Yoshizaki, K., T. Matsuda, N. Nishimoto, T. Kuritani, L. Taeho, K. Aozasa, T. Nakahata, H. Kawai, H. Tagoh, T. Komori, et al. 1989. Pathogenic significance of interleukin-6 (IL-6/BSF-2) in Castleman's disease. Blood 74(4):1360–7.

    PubMed  CAS  Google Scholar 

  254. Beck, J. T., S. M. Hsu, J. Wijdenes, R. Bataille, B. Klein, D. Vesole, K. Hayden, S. Jagannath, and B. Barlogie. 1994. Brief report: alleviation of systemic manifestations of Castleman's disease by monoclonal anti-interleukin-6 antibody. N Engl J Med 330(9):602–5.

    PubMed  CAS  Google Scholar 

  255. Nishimoto, N., M. Sasai, Y. Shima, M. Nakagawa, T. Matsumoto, T. Shirai, T. Kishimoto, and K. Yoshizaki. 2000. Improvement in Castleman's disease by humanized anti-interleukin-6 receptor antibody therapy. Blood 95(1):56–61.

    PubMed  CAS  Google Scholar 

  256. Jung, C. P., B. Emmerich, F. D. Goebel, and J. R. Bogner. 2004. Successful treatment of a patient with HIV-associated multicentric Castleman disease (MCD) with thalidomide. Am J Hematol 75(3):176–7.

    PubMed  Google Scholar 

  257. Boivin, G., A. Gaudreau, and J. P. Routy. 2000. Evaluation of the human herpesvirus 8 DNA load in blood and Kaposi's sarcoma skin lesions from AIDS patients on highly active antiretroviral therapy. AIDS 14(13):1907–10.

    PubMed  CAS  Google Scholar 

  258. de Jong, R. B., P. M. Kluin, S. Rosati, P. L. van Haelst, H. G. Sprenger, and D. J. van Spronsen. 2003. Sustained high levels of serum HHV-8 DNA years before multicentric Castleman's disease despite full suppression of HIV with highly active antiretroviral therapy. AIDS 17(9):1407–8.

    PubMed  Google Scholar 

  259. Lanzafame, M., G. Carretta, M. Trevenzoli, L. Lazzarini, and S. Vento Ercole Concia. 2000. Successful treatment of Castleman's disease with HAART in two HIV-infected patients. J Infect 40(1):90–1.

    PubMed  CAS  Google Scholar 

  260. Dupin, N., A. Krivine, V. Calvez, I. Gorin, N. Franck, and J. P. Escande. 1997. No effect of protease inhibitor on clinical and virological evolution of Castleman's disease in an HIV-1-infected patient. AIDS 11(11):1400–1.

    PubMed  CAS  Google Scholar 

  261. Knowles, D. M., G. Inghirami, A. Ubriaco, and R. Dalla-Favera. 1989. Molecular genetic analysis of three AIDS-associated neoplasms of uncertain lineage demonstrates their B-cell derivation and the possible pathogenetic role of the Epstein-Barr virus. Blood 73(3):792–9.

    PubMed  CAS  Google Scholar 

  262. Horenstein, M. G., R. G. Nador, A. Chadburn, E. M. Hyjek, G. Inghirami, D. M. Knowles, and E. Cesarman. 1997. Epstein-Barr virus latent gene expression in primary effusion lymphomas containing Kaposi's sarcoma-associated herpesvirus/human herpesvirus-8. Blood 90(3):1186–91.

    PubMed  CAS  Google Scholar 

  263. Wilson, J. B., J. L. Bell, A. J. Levine. 1996. Expression of Epstein-Barr virus nuclear antigen-1 induces B cell neoplasia in transgenic mice. Embo J 15(12):3117–26.

    PubMed  CAS  Google Scholar 

  264. Nador, R. G., E. Cesarman, D. M. Knowles, and J. W. Said. 1995. Herpes-like DNA sequences in a body-cavity-based lymphoma in an HIV-negative patient. N Engl J Med 333(14):943.

    PubMed  CAS  Google Scholar 

  265. Ascoli, V., F. Lo Coco, G. Torelli, D. Vallisa, L. Cavanna, C. Bergonzi, and M. Luppi. 2002. Human herpesvirus 8-associated primary effusion lymphoma in HIV–patients: a clinicopidemiologic variant resembling classic Kaposi's sarcoma. Haematologica 87(4):339–43.

    PubMed  Google Scholar 

  266. Boulanger, E., L. Gerard, J. Gabarre, J. M. Molina, C. Rapp, J. F. Abino, J. Cadranel, S. Chevret, and E. Oksenhendler. 2005. Prognostic factors and outcome of human herpesvirus 8-associated primary effusion lymphoma in patients with AIDS. J Clin Oncol 23(19):4372–80.

    PubMed  Google Scholar 

  267. Strauchen, J. A., A. D. Hauser, D. Burstein, R. Jimenez, P. S. Moore, and Y. Chang. 1996. Body cavity-based malignant lymphoma containing Kaposi sarcoma-associated herpesvirus in an HIV-negative man with previous Kaposi sarcoma. Ann Intern Med 125(10):822–5.

    PubMed  CAS  Google Scholar 

  268. Jones, D., M. E. Ballestas, K. M. Kaye, J. M. Gulizia, G. L. Winters, J. Fletcher, D. T. Scadden, and J. C. Aster. 1998. Primary-effusion lymphoma and Kaposi's sarcoma in a cardiac-transplant recipient. N Engl J Med 339(7):444–9.

    PubMed  CAS  Google Scholar 

  269. Cannon, M., and E. Cesarman. 2000. Kaposi's sarcoma-associated herpes virus and acquired immunodeficiency syndrome-related malignancy. Semin Oncol 27(4):409–19.

    PubMed  CAS  Google Scholar 

  270. Parekh, S., and J. Sparano. 2005. Primary Effusion Lymphomas: Biology and Management. In: Volberding, P. A., J. M. Palefsky, editors. Viral and Immunological Malignancies. 1st ed. Hamilton: BC Decker; 2005, pp. 122–7.

    Google Scholar 

  271. Simonelli, C., M. Spina, R. Cinelli, R. Talamini, R. Tedeschi, A. Gloghini, E. Vaccher, A. Carbone, and U. Tirelli. 2003. Clinical features and outcome of primary effusion lymphoma in HIV-infected patients: a single-institution study. J Clin Oncol 21(21):3948–54.

    PubMed  Google Scholar 

  272. Oksenhendler, E., J. P. Clauvel, S. Jouveshomme, F. Davi, and G. Mansour. 1998. Complete remission of a primary effusion lymphoma with antiretroviral therapy. Am J Hematol 57(3):266.

    PubMed  CAS  Google Scholar 

  273. Lowy, D., and P. Howley. 2001. Papillomaviruses. In: Knipe, D., P. Howley, D. Griffin, et al., editors. Fields Virology. 4th ed. Philadelphia: Lippincott Williams & Wilkins; 2001, pp. 2231–64.

    Google Scholar 

  274. Bjorge, T., A. Engeland, T. Luostarinen, J. Mork, R. E. Gislefoss, E. Jellum, P. Koskela, M. Lehtinen, E. Pukkala, S. O. Thoresen, and J. Dillner. 2002. Human papillomavirus infection as a risk factor for anal and perianal skin cancer in a prospective study. Br J Cancer 87(1):61–4.

    PubMed  CAS  Google Scholar 

  275. Durante, A. J., A. B. Williams, M. Da Costa, T. M. Darragh, K. Khoshnood, and J. M. Palefsky. 2003. Incidence of anal cytological abnormalities in a cohort of human immunodeficiency virus-infected women. Cancer Epidemiol Biomarkers Prev 12(7):638–42.

    PubMed  Google Scholar 

  276. Palefsky, J. M., E. A. Holly, J. Gonzales, J. Berline, D. K. Ahn, and J. S. Greenspan. 1991. Detection of human papillomavirus DNA in anal intraepithelial neoplasia and anal cancer. Cancer Res 51(3):1014–9.

    PubMed  CAS  Google Scholar 

  277. Zaki, S. R., R. Judd, L. M. Coffield, P. Greer, F. Rolston, and B. L. Evatt. 1992. Human papillomavirus infection and anal carcinoma. Retrospective analysis by in situ hybridization and the polymerase chain reaction. Am J Pathol 140(6):1345–55.

    PubMed  CAS  Google Scholar 

  278. Petry, K. U., H. Kochel, U. Bode, I. Schedel, S. Niesert, M. Glaubitz, H. Maschek, and H. Kuhnle. 1996. Human papillomavirus is associated with the frequent detection of warty and basaloid high-grade neoplasia of the vulva and cervical neoplasia among immunocompromised women. Gynecol Oncol 60(1):30–4.

    PubMed  CAS  Google Scholar 

  279. Frisch, M., R. J. Biggar, and J. J. Goedert. 2000. Human papillomavirus-associated cancers in patients with human immunodeficiency virus infection and acquired immunodeficiency syndrome. J Natl Cancer Inst 92(18):1500–10.

    PubMed  CAS  Google Scholar 

  280. Ateenyi-Agaba, C. 1995. Conjunctival squamous-cell carcinoma associated with HIV infection in Kampala, Uganda. Lancet 345(8951):695–6.

    PubMed  CAS  Google Scholar 

  281. Waddell, K. M., S. Lewallen, S. B. Lucas, C. Atenyi-Agaba, C. S. Herrington, and G. Liomba. 1996. Carcinoma of the conjunctiva and HIV infection in Uganda and Malawi. Br J Ophthalmol 80(6): 503–8.

    PubMed  CAS  Google Scholar 

  282. Moubayed, P., H. Mwakyoma, and D. T. Schneider. 2004. High frequency of human papillomavirus 6/11, 16, and 18 infections in precancerous lesions and squamous cell carcinoma of the conjunctiva in subtropical Tanzania. Am J Clin Pathol 122(6):938–43.

    PubMed  Google Scholar 

  283. Barbosa, M. S., and R. Schlegel. 1989. The E6 and E7 genes of HPV-18 are sufficient for inducing two-stage in vitro transformation of human keratinocytes. Oncogene 4(12):1529–32.

    PubMed  CAS  Google Scholar 

  284. Munger, K., W. C. Phelps, V. Bubb, P. M. Howley, and R. Schlegel. 1989. The E6 and E7 genes of the human papillomavirus type 16 together are necessary and sufficient for transformation of primary human keratinocytes. J Virol 63(10):4417–21.

    PubMed  CAS  Google Scholar 

  285. Riley, R. R., S. Duensing, T. Brake, K. Munger, P. F. Lambert, and J. M. Arbeit. 2003. Dissection of human papillomavirus E6 and E7 function in transgenic mouse models of cervical carcinogenesis. Cancer Res 63(16):4862–71.

    PubMed  CAS  Google Scholar 

  286. Tornesello, M. L., F. M. Buonaguro, E. Beth-Giraldo, and G. Giraldo. 1993. Human immunodeficiency virus type 1 tat gene enhances human papillomavirus early gene expression. Intervirology 36(2):57–64.

    PubMed  CAS  Google Scholar 

  287. Vernon, S. D., C. E. Hart, W. C. Reeves, and J. P. Icenogle. 1993. The HIV-1 tat protein enhances E2-dependent human papillomavirus 16 transcription. Virus Res 27(2):133–45.

    PubMed  CAS  Google Scholar 

  288. IARC. 1996. IARC W group on the evaluation of carcinogenic risk to humans. Human Immunodeficinecy viruses and human T-cell lymphotropic viruses; 1996.

    Google Scholar 

  289. Serraino, D., L. Dal Maso, C. La Vecchia, and S. Franceschi. 2002. Invasive cervical cancer as an AIDS-defining illness in Europe. AIDS 16(5):781–6.

    PubMed  Google Scholar 

  290. Serraino, D., P. Carrieri, C. Pradier, E. Bidoli, M. Dorrucci, E. Ghetti, A. Schiesari, R. Zucconi, P. Pezzotti, P. Dellamonica, S. Franceschi, and G. Rezza. 1999. Risk of invasive cervical cancer among women with, or at risk for, HIV infection. Int J Cancer 82(3):334–7.

    PubMed  CAS  Google Scholar 

  291. Sitas, F., R. Pacella-Norman, H. Carrara, M. Patel, P. Ruff, R. Sur, U. Jentsch, M. Hale, P. Rowji, D. Saffer, M. Connor, D. Bull, R. Newton, and V. Beral. 2000. The spectrum of HIV-1 related cancers in South Africa. Int J Cancer 88(3):489–92.

    PubMed  CAS  Google Scholar 

  292. Gichangi, P., H. De Vuyst, B. Estambale, K. Rogo, J. Bwayo, and M. Temmerman. 2002. HIV and cervical cancer in Kenya. Int J Gynaecol Obstet 76(1):55–63.

    PubMed  CAS  Google Scholar 

  293. La Ruche, G., B. You, I. Mensah-Ado, C. Bergeron, C. Montcho, R. Ramon, K. Toure-Coulibaly, C. Welffens-Ekra, F. Dabis, and G. Orth. 1998. Human papillomavirus and human immunodeficiency virus infections: relation with cervical dysplasia–neoplasia in African women. Int J Cancer 76(4):480–6.

    PubMed  Google Scholar 

  294. Patil, P., B. Elem, and A. Zumla. 1995. Pattern of adult malignancies in Zambia (1980–1989) in light of the human immunodeficiency virus type 1 epidemic. J Trop Med Hyg 98(4):281–4.

    PubMed  CAS  Google Scholar 

  295. Newton, R., A. Grulich, V. Beral, B. Sindikubwabo, P. J. Ngilimana, A. Nganyira, and D. M. Parkin. 1995. Cancer and HIV infection in Rwanda. Lancet 345(8961):1378–9.

    PubMed  CAS  Google Scholar 

  296. International Conference on HIV and Cancer. 2000. Highly active antiretroviral therapy and incidence of cancer in human immunodeficiency virus-infected adults. J Natl Cancer Inst 92(22):1823–30.

    Google Scholar 

  297. Mandelblatt, J. S., P. Kanetsky, L. Eggert, and K. Gold. 1999. Is HIV infection a cofactor for cervical squamous cell neoplasia? Cancer Epidemiol Biomarkers Prev 8(1):97–106.

    PubMed  CAS  Google Scholar 

  298. Massad, L. S., K. A. Riester, K. M. Anastos, R. G. Fruchter, J. M. Palefsky, R. D. Burk, D. Burns, R. M. Greenblatt, L. I. Muderspach, and P. Miotti. 1999. Prevalence and predictors of squamous cell abnormalities in Papanicolaou smears from women infected with HIV-1. Women's Interagency HIV Study Group. J Acquir Immune Defic Syndr 21(1):33–41.

    PubMed  CAS  Google Scholar 

  299. Duerr, A., B. Kieke, D. Warren, K. Shah, R. Burk, J. F. Peipert, P. Schuman, and R. S. Klein. 2001. Human papillomavirus-associated cervical cytologic abnormalities among women with or at risk of infection with human immunodeficiency virus. Am J Obstet Gynecol 184(4):584–90.

    PubMed  CAS  Google Scholar 

  300. Ahdieh, L., A. Munoz, D. Vlahov, C. L. Trimble, L. A. Timpson, and K. Shah. 2000. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women. Am J Epidemiol 151(12):1148–57.

    PubMed  CAS  Google Scholar 

  301. US Public Health Service (USPHS) and Infectious Diseases Society of America. Guidelines for Preventing Opportunistic Infections Among HIV-Infected Persons. Accessed May 1, 2006.

    Google Scholar 

  302. Kurman, R. J., D. E. Henson, A. L. Herbst, K. L. Noller, M. H. Schiffman. 1994. Interim guidelines for management of abnormal cervical cytology. The 1992 National Cancer Institute Workshop. JAMA 271(23):1866–9.

    Google Scholar 

  303. Tate, D. R., and R. J. Anderson. 2002. Recrudescence of cervical dysplasia among women who are infected with the human immunodeficiency virus: a case-control analysis. Am J Obstet Gynecol 186(5):880–2.

    PubMed  Google Scholar 

  304. Robinson, W. R., C. A. Hamilton, S. H. Michaels, and P. Kissinger. 2001. Effect of excisional therapy and highly active antiretroviral therapy on cervical intraepithelial neoplasia in women infected with human immunodeficiency virus. Am J Obstet Gynecol 184(4):538–43.

    PubMed  CAS  Google Scholar 

  305. Orlando, G., M. M. Fasolo, M. Schiavini, R. Signori, and A. Cargnel. 1999. Role of highly active antiretroviral therapy in human papillomavirus-induced genital dysplasia in HIV-1-infected patients. AIDS 13(3):424–5.

    PubMed  CAS  Google Scholar 

  306. Lillo, F. B., D. Ferrari, F. Veglia, M. Origoni, M. A. Grasso, S. Lodini, E. Mastrorilli, G. Taccagni, A. Lazzarin, and C. Uberti-Foppa. 2001. Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy. J Infect Dis 184(5):547–51.

    PubMed  CAS  Google Scholar 

  307. Moore, A. L., C. A. Sabin, S. Madge, A. Mocroft, W. Reid, and M. A. Johnson. 2002. Highly active antiretroviral therapy and cervical intraepithelial neoplasia. AIDS 16(6):927–9.

    PubMed  Google Scholar 

  308. Heard, I., V. Schmitz, D. Costagliola, G. Orth, and M. D. Kazatchkine. 1998. Early regression of cervical lesions in HIV-seropositive women receiving highly active antiretroviral therapy. AIDS 12(12):1459–64.

    PubMed  CAS  Google Scholar 

  309. Minkoff, H., L. Ahdieh, L. S. Massad, K. Anastos, D. H. Watts, S. Melnick, L. Muderspach, R. Burk, and J. Palefsky. 2001. The effect of highly active antiretroviral therapy on cervical cytologic changes associated with oncogenic HPV among HIV-infected women. AIDS 15(16):2157–64.

    PubMed  CAS  Google Scholar 

  310. Heard, I., J. M. Tassie, M. D. Kazatchkine, and G. Orth. 2002. Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women. AIDS 16(13): 1799–1802.

    PubMed  CAS  Google Scholar 

  311. Selik, R. M., and C. S. Rabkin. 1998. Cancer death rates associated with human immunodeficiency virus infection in the United States. J Natl Cancer Inst 90(17):1300–2.

    PubMed  CAS  Google Scholar 

  312. Daling, J. R., N. S. Weiss, T. G. Hislop, C. Maden, R. J. Coates, K. J. Sherman, R. L. Ashley, M. Beagrie, J. A. Ryan, and L. Corey. 1987. Sexual practices, sexually transmitted diseases, and the incidence of anal cancer. N Engl J Med 317(16):973–7.

    PubMed  CAS  Google Scholar 

  313. Melbye, M., C. Rabkin, M. Frisch, and R. J. Biggar. 1994. Changing patterns of anal cancer incidence in the United States, 1940–1989. Am J Epidemiol 139(8):772–80.

    PubMed  CAS  Google Scholar 

  314. Johnson, L. G., M. M. Madeleine, L. M. Newcomer, S. M. Schwartz, and J. R. Daling. 2004. Anal cancer incidence and survival: the surveillance, epidemiology, and end results experience, 1973–2000. Cancer 101(2):281–8.

    PubMed  Google Scholar 

  315. Cress, R. D., and E. A. Holly. 2003. Incidence of anal cancer in California: increased incidence among men in San Francisco, 1973–1999. Prev Med 36(5):555–60.

    PubMed  Google Scholar 

  316. Grulich, A. E., X. Wan, M. G. Law, M. Coates, and J. M. Kaldor. 1999. Risk of cancer in people with AIDS. AIDS 13(7):839–43.

    PubMed  CAS  Google Scholar 

  317. Clifford, G. M., J. Polesel, M. Rickenbach, L. Dal Maso, O. Keiser, A. Kofler, E. Rapiti, F. Levi, G. Jundt, T. Fisch, A. Bordoni, D. De Weck, S. Franceschi. 2005. Cancer risk in the Swiss HIV Cohort Study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy. J Natl Cancer Inst 97(6):425–32.

    PubMed  Google Scholar 

  318. Bower, M., T. Powles, T. Newsom-Davis, C. Thirlwell, J. Stebbing, S. Mandalia, M. Nelson, and B. Gazzard. 2004. HIV-Associated Anal Cancer: Has Highly Active Antiretroviral Therapy Reduced the Incidence or Improved the Outcome? J Acquir Immune Defic Syndr 37(5):1563–5.

    PubMed  Google Scholar 

  319. Palefsky, J. M., E. A. Holly, M. L. Ralston, M. Da Costa, H. Bonner, N. Jay, J. M. Berry, and T. M. Darragh. 2001. Effect of highly active antiretroviral therapy on the natural history of anal squamous intraepithelial lesions and anal human papillomavirus infection. J Acquir Immune Defic Syndr 28(5):422–8.

    PubMed  CAS  Google Scholar 

  320. Piketty, C., T. M. Darragh, I. Heard, M. Da Costa, P. Bruneval, M. D. Kazatchkine, and J. M. Palefsky. 2004. High prevalence of anal squamous intraepithelial lesions in HIV-positive men despite the use of highly active antiretroviral therapy. Sex Transm Dis 31(2):96–9.

    PubMed  Google Scholar 

  321. Kiviat, N. B., M Redman, S. Hawes, T. Lampinen, P. Nelspon, and C. W. Critchlow. 2002. The effect of HAART on detection of anal HPV and squamous intraepithelial lesions among HIV infected homosexual men. Sixth International Conference on Malignancies in AIDS and Other Immunodeficiencies, Bethesda, MD, USA; 2002.

    Google Scholar 

  322. Wilkin, T. J., S. Palmer, K. F. Brudney, M. A. Chiasson, and T. C. Wright. Anal intraepithelial neoplasia in heterosexual and homosexual HIV-positive men with access to antiretroviral therapy. J Infect Dis 190(9):1685–91.

    Google Scholar 

  323. Palefsky, J. M., E. A. Holly, J. T. Efirdc, M. Da Costa, N. Jay, J. M. Berry, and T. M. Darragh. 2005. Anal intraepithelial neoplasia in the highly active antiretroviral therapy era among HIV-positive men who have sex with men. AIDS 19(13):1407–14.

    PubMed  Google Scholar 

  324. Palefsky, J. M., E. A. Holly, M. L. Ralston, and N. Jay. 1998. Prevalence and risk factors for human papillomavirus infection of the anal canal in human immunodeficiency virus (HIV)-positive and HIV-negative homosexual men. J Infect Dis 177(2):361–7.

    PubMed  CAS  Google Scholar 

  325. Sayers, S. J., A. McMillan, and E. McGoogan. 1998. Anal cytological abnormalities in HIV-infected homosexual men. Int J STD AIDS 9(1):37–40.

    PubMed  CAS  Google Scholar 

  326. Friedman, H. B., A. J. Saah, M. E. Sherman, A. E. Busseniers, W. C. Blackwelder, R. A. Kaslow, A. M. Ghaffari, R. W. Daniel, and K. V. Shah. 1998. Human papillomavirus, anal squamous intraepithelial lesions, and human immunodeficiency virus in a cohort of gay men. J Infect Dis 178(1): 45–52.

    PubMed  CAS  Google Scholar 

  327. Lacey, H. B., G. E. Wilson, P. Tilston, E. G. Wilkins, A. S. Bailey, G. Corbitt, and P. M. Green. 1999. A study of anal intraepithelial neoplasia in HIV positive homosexual men. Sex Transm Infect 75(3):172–7.

    PubMed  CAS  Google Scholar 

  328. Goldstone, S. E., B. Winkler, L. J. Ufford, E. Alt, J. M. Palefsky. 2001. High prevalence of anal squamous intraepithelial lesions and squamous-cell carcinoma in men who have sex with men as seen in a surgical practice. Dis Colon Rectum 44(5):690–8.

    PubMed  CAS  Google Scholar 

  329. Piketty, C., T. M. Darragh, M. Da Costa, P. Bruneval, I. Heard, M. D. Kazatchkine, and J. M. Palefsky. 2003. High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse. Ann Intern Med 138(6):453–9.

    PubMed  Google Scholar 

  330. Lee, A., T. Young, D. Hanks, R. Ung, and J. Stansell. 2004. The evaluation of anal dysplasia with anal cytology (PAP) followed by high resolution anoscopy (HRA) and biopsy in HIV-infected men. International Conference on AIDS, Bangkok, Thailand; 2004.

    Google Scholar 

  331. Chin-Hong, P. V., M. D. Guimaraes, D. Bonfim, M. Da Casta, T. Darragh, B. Grinsztejn, S. B. May, J. H. Pilotto, and J. M. Palefsky. 2004. Anal squamous intraepithelial lesions and HPV infection in hiv-positive men in Brazil. International Conference on AIDS, Bangkok; 2004.

    Google Scholar 

  332. Kreuter, A., N. H. Brockmeyer, B. Hochdorfer, S. J. Weissenborn, M. Stucker, J. Swoboda, P. Altmeyer, H. Pfister, and U. Wieland. 2005. Clinical spectrum and virologic characteristics of anal intraepithelial neoplasia in HIV infection. J Am Acad Dermatol 52(4):603–8.

    PubMed  Google Scholar 

  333. Palefsky, J. M., E. A. Holly, M. L. Ralston, N. Jay, J. M. Berry, and T. M. Darragh. 1998. High incidence of anal high-grade squamous intra-epithelial lesions among HIV-positive and HIV-negative homosexual and bisexual men. AIDS 12(5):495–503.

    PubMed  CAS  Google Scholar 

  334. Holly, E. A., M. L. Ralston, T. M. Darragh, R. M. Greenblatt, N. Jay, and J. M. Palefsky. 2001. Prevalence and risk factors for anal squamous intraepithelial lesions in women. J Natl Cancer Inst 93(11):843–9.

    PubMed  CAS  Google Scholar 

  335. Palefsky, J. M., E. A. Holly, M. L. Ralston, M. Da Costa, and R. M. Greenblatt. 2001. Prevalence and risk factors for anal human papillomavirus infection in human immunodeficiency virus (HIV)-positive and high-risk HIV-negative women. J Infect Dis 183(3):383–91.

    PubMed  CAS  Google Scholar 

  336. Hillemanns, P., T. V. Ellerbrock, P. Dole, X. W. Sun, M. A. Chiasson, and T. C. Wright. 1996. Anal HPV infection and anal cytologic abnormalities in HIV-seropostiive women. Internation Conference on AIDS, Vancouver, Canada; 1996.

    Google Scholar 

  337. Melbye, M., E. Smith, J. Wohlfahrt, A. Osterlind, M. Orholm, O. J. Bergmann, L. Mathiesen, T. M. Darragh, and J. M. Palefsky. 1996. Anal and cervical abnormality in women–prediction by human papillomavirus tests. Int J Cancer 68(5):559–64.

    PubMed  CAS  Google Scholar 

  338. Bosch, F. X., M. M. Manos, N. Munoz, M. Sherman, A. M. Jansen, J. Peto, M. H. Schiffman, V. Moreno, R. Kurman, and K. V. Shah. 1995. Prevalence of human papillomavirus in cervical cancer: a worldwide perspective. International biological study on cervical cancer (IBSCC) Study Group. J Natl Cancer Inst 87(11):796–802.

    PubMed  CAS  Google Scholar 

  339. Beckmann, A. M., J. R. Daling, K. J. Sherman, C. Maden, B. A. Miller, R. J. Coates, N. B. Kiviat, D. Myerson, N. S. Weiss, T. G. Hislop, et al. 1989. Human papillomavirus infection and anal cancer. Int J Cancer 43(6):1042–9.

    PubMed  CAS  Google Scholar 

  340. Darragh, T., G. Birdson, R. Luff, and D. Davey. 2004. Chapter 8: Anal-Rectal Cytology. 2nd ed. New York: Springer-Verlag; 2004.

    Google Scholar 

  341. New York State AIDS Malignancy Consortium. 2004. Criteria for the medical care of adults with HIV infection; March 2004.

    Google Scholar 

  342. Palefsky, J. M., E. A. Holly, C. J. Hogeboom, J. M. Berry, N. Jay, and T. M. Darragh. 1997. Anal cytology as a screening tool for anal squamous intraepithelial lesions. J Acquir Immune Defic Syndr Hum Retrovirol 14(5):415–22.

    PubMed  CAS  Google Scholar 

  343. Cocchi, V., D. Carretti, S. Fanti, P. Baldazzi, M. T. Casotti, R. Piazzi, L. Prosperi, and A. M. Morselli-Labate. 1997. Intralaboratory quality assurance in cervical/vaginal cytology: evaluation of intercytologist diagnostic reproducibility. Diagn Cytopathol 16(1):87–92.

    PubMed  CAS  Google Scholar 

  344. Stoler, M. H., and M. Schiffman. 2001. Interobserver reproducibility of cervical cytologic and histologic interpretations: realistic estimates from the ASCUS-LSIL Triage Study. JAMA 285(11):1500–5.

    PubMed  CAS  Google Scholar 

  345. Woodhouse, S. L., J. F. Stastny, P. E. Styer, M. Kennedy, A. H. Praestgaard, and D. D. Davey. 1999. Interobserver variability in subclassification of squamous intraepithelial lesions: results of the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Arch Pathol Lab Med 123(11):1079–84.

    PubMed  CAS  Google Scholar 

  346. Goldie, S. J., K. M. Kuntz, M. C. Weinstein, K. A. Freedberg, M. L. Welton, and J. M. Palefsky. 1999. The clinical effectiveness and cost-effectiveness of screening for anal squamous intraepithelial lesions in homosexual and bisexual HIV-positive men. JAMA 281(19):1822–9.

    PubMed  CAS  Google Scholar 

  347. Arnott, S. J., D. Cunningham, J. Gallagher, et al. 1996. Epidermoid anal cancer: results from the UKCCCR randomised trial of radiotherapy alone versus radiotherapy, 5-fluorouracil, and mitomycin. UKCCCR Anal Cancer Trial Working Party. UK Co-ordinating Committee on Cancer Research. Lancet 348(9034):1049–54.

    Google Scholar 

  348. Myerson, R. J., F. Kong, E. H. Birnbaum, J. W. Fleshman, I. J. Kodner, J. Picus, G. A. Ratkin, T. E. Read, and B. J. Walz. 2001. Radiation therapy for epidermoid carcinoma of the anal canal, clinical and treatment factors associated with outcome. Radiother Oncol 61(1):15–22.

    PubMed  CAS  Google Scholar 

  349. Pitcher, M. E., T. I. Davidson, C. Fisher, and J. M. Thomas. 1994. Post irradiation sarcoma of soft tissue and bone. Eur J Surg Oncol 20(1):53–6.

    PubMed  CAS  Google Scholar 

  350. Jephcott, C. R., C. Paltiel, and J. Hay. 2004. Quality of life after non-surgical treatment of anal carcinoma: a case control study of long-term survivors. Clin Oncol (R Coll Radiol) 16(8):530–5.

    CAS  Google Scholar 

  351. Flam, M., M. John, T. F. Pajak, N. Petrelli, R. Myerson, S. Doggett, J. Quivey, M. Rotman, H. Kerman, L. Coia, and K. Murray. 1996. Role of mitomycin in combination with fluorouracil and radiotherapy, and of salvage chemoradiation in the definitive nonsurgical treatment of epidermoid carcinoma of the anal canal: results of a phase III randomized intergroup study. J Clin Oncol 14(9):2527–39.

    PubMed  CAS  Google Scholar 

  352. Gerard, J. P., L. Ayzac, D. Hun, P. Romestaing, R. Coquard, J. M. Ardiet, and F. Mornex. 1998. Treatment of anal canal carcinoma with high dose radiation therapy and concomitant fluorouracil-cisplatinum. Long-term results in 95 patients. Radiother Oncol 46(3):249–56.

    PubMed  CAS  Google Scholar 

  353. Doci, R., R. Zucali, L. Bombelli, F. Montalto, and G. Lamonica. 1992. Combined chemoradiation therapy for anal cancer. A report of 56 cases. Ann Surg 215(2):150–6.

    PubMed  CAS  Google Scholar 

  354. John, M., M. Flam, and N. Palma. 1996. Ten-year results of chemoradiation for anal cancer: focus on late morbidity. Int J Radiat Oncol Biol Phys 34(1):65–9.

    PubMed  CAS  Google Scholar 

  355. Cleator, S., K. Fife, M. Nelson, B. Gazzard, R. Phillips, and M. Bower. 2000. Treatment of HIV-associated invasive anal cancer with combined chemoradiation. Eur J Cancer 36(6):754–8.

    PubMed  CAS  Google Scholar 

  356. Stadler, R. F., S. G. Gregorcyk, D. M. Euhus, R. J. Place, P. J. Huber, and C. L. Simmang. 2004. Outcome of HIV-infected patients with invasive squamous-cell carcinoma of the anal canal in the era of highly active antiretroviral therapy. Dis Colon Rectum 47(8):1305–9.

    PubMed  Google Scholar 

  357. Bottomley, D. M., N. Aqel, G. Selvaratnam, and R. H. Phillips. 1996. Epidermoid anal cancer in HIV infected patients. Clin Oncol (R Coll Radiol) 8(5):319–22.

    CAS  Google Scholar 

  358. Hocht, S., T. Wiegel, A. J. Kroesen, W. E. Berdel, N. Runkel, and W. Hinkelbein. 1997. Low acute toxicity of radiotherapy and radiochemotherapy in patients with cancer of the anal canal and HIV-infection. Acta Oncol 36(8):799–802.

    PubMed  CAS  Google Scholar 

  359. Peddada, A. V., D. E. Smith, A. R. Rao, D. B. Frost, and A. R. Kagan. 1997. Chemotherapy and low-dose radiotherapy in the treatment of HIV-infected patients with carcinoma of the anal canal. Int J Radiat Oncol Biol Phys 37(5):1101–5.

    PubMed  CAS  Google Scholar 

  360. Hoffman, R., M. L. Welton, B. Klencke, V. Weinberg, and R. Krieg. 1999. The significance of pretreatment CD4 count on the outcome and treatment tolerance of HIV-positive patients with anal cancer. Int J Radiat Oncol Biol Phys 44(1):127–31.

    PubMed  CAS  Google Scholar 

  361. Blazy, A., C. Hennequin, J. M. Gornet, A. Furco, L. Gerard, M. Lemann, and C. Maylin. 2005. Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy. Dis Colon Rectum 48(6):1176–81.

    PubMed  Google Scholar 

  362. Palefsky, J. M., Ea. Holly, and M. Ralston. 2002. Effect of HAART on incidence of anal intraepithelial neoplasia grade 3 among HIV-positive men who have sex with men. Fourteenth International Conference on AIDS, Barcelona, Spain; 2002.

    Google Scholar 

  363. Chang, G. J., J. M. Berry, N. Jay, J. M. Palefsky, and M. L. Welton. 2002. Surgical treatment of high-grade anal squamous intraepithelial lesions: a prospective study. Dis Colon Rectum 45(4):453–8.

    PubMed  Google Scholar 

  364. Goldstone, S. E., A. Z. Kawalek, and J. W. Huyett. 2005. Infrared coagulator: a useful tool for treating anal squamous intraepithelial lesions. Dis Colon Rectum 48(5):1042–1054.

    PubMed  Google Scholar 

  365. Kreuter, A., B. Hochdorfer, M. Stucker, P. Altmeyer, U. Weiland, M. A. Conant, and N. H. Brockmeyer. 2004. Treatment of anal intraepithelial neoplasia in patients with acquired HIV with imiquimod 5% cream. J Am Acad Dermatol 50(6):980–1.

    PubMed  Google Scholar 

  366. Graham, B. D., A. B. Jetmore, J. E. Foote, and L. K. Arnold. 2005. Topical 5-fluorouracil in the management of extensive anal Bowen's disease: a preferred approach. Dis Colon Rectum 48(3):444–50.

    PubMed  Google Scholar 

  367. Biggar, R. J., E. A. Engls, S, Ly, A. Kahn, M. J. Schymura, J. Sackoff, P. Virgo, and E. M. Pfeiffer. 2005. Survival after cancer diagnosis in persons with AIDS. J Acquir Immune Def Syndr., Jul 1; 39(3): 293–9.

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Center for Clinical Studies, Houston, TX

    Anita Arora MD

  2. Baylor College of Medicine, Houston, TX

    Elizabeth Chiao MD

  3. University of Texas Health Science Center, Houston, TX

    Stephen K. Tyring MD, Ph.D.

Authors
  1. Anita Arora MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Elizabeth Chiao MD
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Stephen K. Tyring MD, Ph.D.
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

C. Meyers

Rights and permissions

Reprints and permissions

Copyright information

© 2007 Springer Science+Business Media, LLC

About this chapter

Cite this chapter

Arora, A., Chiao, E., Tyring, S.K. (2007). Aids Malignancies. In: Meyers, C. (eds) Aids-Associated Viral Oncogenesis. Cancer Treatment and Research, vol 133. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-46816-7_2

Download citation

  • DOI: https://doi.org/10.1007/978-0-387-46816-7_2

  • Publisher Name: Springer, Boston, MA

  • Print ISBN: 978-0-387-46804-4

  • Online ISBN: 978-0-387-46816-7

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation